# EDGAR Filing Document

**Accession Number:** 0001631942
**File Stem:** 0001683863-23-001709
**Filing Date:** 2023-3
**Character Count:** 158299
**Document Hash:** 9e49c574ef3afa2ca2cad684e549f8f6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683863-23-001709.hdr.sgml**: 20230302

**ACCESSION NUMBER**: 0001683863-23-001709

**CONFORMED SUBMISSION TYPE**: N-CSR

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230302

**DATE AS OF CHANGE**: 20230302

**EFFECTIVENESS DATE**: 20230302

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** John Hancock Collateral Trust
- **CENTRAL INDEX KEY:** 0001631942
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-CSR
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23027
- **FILM NUMBER:** 23699058

**BUSINESS ADDRESS:**
- **STREET 1:** C/O JOHN HANCOCK FUNDS
- **STREET 2:** 200 BERKELEY STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** 800-225-5291

**MAIL ADDRESS:**
- **STREET 1:** C/O JOHN HANCOCK FUNDS
- **STREET 2:** 200 BERKELEY STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116

## Series and Classes Contracts Data

### John Hancock Collateral Trust (Series ID: S000048934)

| Class ID   | Class Name                    | Ticker Symbol   |
|:---|:---|:---|
| C000154149 | John Hancock Collateral Trust |  |

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

**FORM N-CSR**

**CERTIFIED SHAREHOLDER REPORT OF REGISTERED**

**MANAGEMENT INVESTMENT COMPANIES**

Investment Company Act file number 811-23027

<u>John Hancock Collateral Trust</u>

(Exact name of registrant as specified in charter)

<u>200 Berkeley Street, Boston, Massachusetts 02116</u> (Address of principal executive offices) (Zip code)

Salvatore Schiavone

Treasurer

200 Berkeley Street

<u>Boston, Massachusetts 02116</u>

(Name and address of agent for service) Registrant's telephone number, including area code: <u>617-543-9634</u>

Date of fiscal year end: December 31 <br> Date of reporting period: December 31, 2022

------

ITEM 1. REPORTS TO STOCKHOLDERS.

------

![](imga58d688d1.gif)

![](img6e597bbb2.gif)

Annual report

## John Hancock

## Collateral Trust
Fixed income

December 31, 2022

![](imgabce865d3.gif)

------

John Hancock

Collateral Trust

Table of contents

---

| | |
|:---|:---|
| &nbsp;&nbsp;**2** | &nbsp;&nbsp;[Your fund at a glance](#xx_f7e5847c-07c4-4004-b2fc-a10e0d6b15ef_1) |
| &nbsp;&nbsp;**5** | &nbsp;&nbsp;[Your expenses](#xx_6581f014-e39a-4271-8483-6a86cb92ff1c_1) |
| &nbsp;&nbsp;**7** | &nbsp;&nbsp;[Fund's investments](#xx_32024cd7-1323-4702-ab1d-3a6100b935e9_1) |
| **12** | &nbsp;&nbsp;[Financial statements](#xx_b4dbc14b-7045-4165-9867-f664774a5ed2_1) |
| **15** | &nbsp;&nbsp;[Financial highlights](#xx_961de704-254c-47b9-bed6-7ac093ea6206_1) |
| **16** | &nbsp;&nbsp;[Notes to financial statements](#xx_f67b8b11-95df-4513-87cc-b0e02e97b3af_1) |
| **20** | &nbsp;&nbsp;[Report of independent registered public accounting firm](#xx_65ab3d41-9516-4aca-a3a4-9d50aad871ae_1) |
| **21** | &nbsp;&nbsp;[Shareholder meeting](#xx_b4e84090-ff0b-48a8-a0e0-c72b1a1e6244_1) |
| **22** | &nbsp;&nbsp;[Trustees and Officers](#xx_7b732a0d-2326-44f9-bf2e-7fff9f011dfa_1) |
| **26** | &nbsp;&nbsp;[More information](#xx_15963960-f785-41d7-bf31-9fbcfffffba4_1) |

---

1 JOHN HANCOCK COLLATERAL TRUST \| ANNUAL REPORT

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

Your fund at a glance

#### INVESTMENT OBJECTIVE

------

The fund seeks current income, while maintaining adequate liquidity, safeguarding the return of principal and minimizing risk of default.

#### AVERAGE ANNUAL TOTAL RETURNS AS OF 12/31/2022 (%)

------

![](img50a8860b4.gif)

The Intercontinental Exchange (ICE) Bank of America (BofA) 3-Month U.S. Treasury Bill Index is an unmanaged index that seeks to measure the performance of outstanding U.S. Treasury bills that mature closest to, but not beyond, three months from the rebalancing date.

It is not possible to invest directly in an index. Index figures do not reflect expenses or sales charges, which would result in lower returns.

**The past performance shown here reflects reinvested distributions and the beneficial effect of any expense reductions, and does not guarantee future results. Shares will fluctuate in value and, when redeemed, may be worth more or less than their original cost. Current month-end performance may be lower or higher than the performance cited, and can be obtained by calling 800-225-5291. For further information on the fund's objectives, risks, and strategy, see the fund's registration statement.**

ANNUAL REPORT \| JOHN HANCOCK COLLATERAL TRUST 2

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

#### MATURITY COMPOSITION AS OF 12/31/2022 (% of net assets)

------

![](img959debe95.gif)

#### PORTFOLIO COMPOSITION AS OF 12/31/2022 (% of net assets)

------

![](img329c60586.gif)

3 JOHN HANCOCK COLLATERAL TRUST \| ANNUAL REPORT

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

---

| | |
|:---|:---|
| **TOP 10 ISSUERS AS OF 12/31/2022 (% of net assets)** | **TOP 10 ISSUERS AS OF 12/31/2022 (% of net assets)** |
| Federal Home Loan Bank, 2.559% to 5.014%, 1-3-23 to 12-12-23 | &nbsp;&nbsp;11.7 |
| Federal Farm Credit Bank, 4.380% to 4.749%, 1-13-23 to 12-5-24 | &nbsp;&nbsp;&nbsp;&nbsp;5.3 |
| Cargill Global Funding PLC, 4.331% to 4.332%, 1-3-23 to 1-4-23 | &nbsp;&nbsp;&nbsp;&nbsp;5.1 |
| Old Line Funding LLC, 4.623% to 4.948%, 1-17-23 to 6-21-23 | &nbsp;&nbsp;&nbsp;&nbsp;4.2 |
| Gotham Funding Corp., 4.061% to 5.156%, 1-10-23 to 5-3-23 | &nbsp;&nbsp;&nbsp;&nbsp;3.4 |
| National Rural Utilities Cooperative Finance Corp., 4.631% to 4.852%, 1-19-23 to 8-7-23 | &nbsp;&nbsp;&nbsp;&nbsp;3.2 |
| Royal Bank of Canada, 2.507% to 5.161%, 2-28-23 to 10-19-23 | &nbsp;&nbsp;&nbsp;&nbsp;2.9 |
| Philip Morris International, Inc., 4.480%, 2-2-23 | &nbsp;&nbsp;&nbsp;&nbsp;2.9 |
| The Bank of Nova Scotia, 4.361% to 5.251%, 1-30-23 to 9-15-23 | &nbsp;&nbsp;&nbsp;&nbsp;2.9 |
| Manhattan Asset Funding Company LLC, 4.644% to 5.297%, 1-6-23 to 6-20-23 | &nbsp;&nbsp;&nbsp;&nbsp;2.5 |
| **TOTAL** | &nbsp;&nbsp;**44.1** |

---

#### Notes about risk
The fund is subject to various risks as described in the fund's registration statement. Political tensions and armed conflicts, including the Russian invasion of Ukraine, and any resulting economic sanctions on entities and/or individuals of a particular country could lead such a country into an economic recession. The COVID-19 disease has resulted in significant disruptions to global business activity. A widespread health crisis such as a global pandemic could cause substantial market volatility, exchange-trading suspensions, and closures, which may lead to less liquidity in certain instruments, industries, sectors, or the markets, generally, and may ultimately affect fund performance. For more information, please refer to the "Risks" section of the registration statement.

ANNUAL REPORT \| JOHN HANCOCK COLLATERAL TRUST 4

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

Your expenses

These examples are intended to help you understand your ongoing operating expenses of investing in the fund so you can compare these costs with the ongoing costs of investing in other mutual funds.

#### Understanding fund expenses
As a shareholder of the fund, you incur two types of costs:

■**Transaction costs,** which include sales charges (loads) on purchases or redemptions (if applicable), minimum account fee charge, etc.

■**Ongoing operating expenses,** including management fees, distribution and service fees (if applicable), and other fund expenses.

We are presenting only your ongoing operating expenses here.

#### Actual expenses/actual returns
The first line of the table on the following page is intended to provide information about the fund's actual ongoing operating expenses, and is based on the fund's actual return. It assumes an account value of $1,000.00 on July 1, 2022, with the same investment held until December 31, 2022.

Together with the value of your account, you may use this information to estimate the operating expenses that you paid over the period. Simply divide your account value at December 31, 2022, by $1,000.00, then multiply it by the "expenses paid" for your share class from the table. For example, for an account value of $8,600.00, the operating expenses should be calculated as follows:

![](img9d5b92e17.gif)

#### Hypothetical example for comparison purposes
The second line of the table on the following page allows you to compare the fund's ongoing operating expenses with those of any other fund. It provides an example of the fund's hypothetical account values and hypothetical expenses based on each class's actual expense ratio and an assumed 5% annualized return before expenses (which is not the class's actual return). It assumes an account value of $1,000.00 on July 1, 2022, with the same investment held until December 31, 2022. Look in any other fund shareholder report to find its hypothetical example and you will be able to compare these expenses. Please remember that these hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period.

5 JOHN HANCOCK COLLATERAL TRUST \| ANNUAL REPORT

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

Remember, these examples do not include any transaction costs, therefore, these examples will not help you to determine the relative total costs of owning different funds. If transaction costs were included, your expenses would have been higher. See the registration statements for details regarding transaction costs.

#### SHAREHOLDER EXPENSE EXAMPLE CHART

------

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Account<br> value on<br> 7-1-2022** | **Ending<br> value on<br> 12-31-2022** | **Expenses<br> paid during<br> 12-31-2022<sup>1</sup>** | **Annualized<br> expense<br> ratio** |
| Actual expenses/actual returns | $1000.00 | $1014.80 | $0.46 | 0.09% |
| Hypothetical example | &nbsp;&nbsp;&nbsp;1000.00 | &nbsp;&nbsp;&nbsp;1024.80 | &nbsp;&nbsp;&nbsp;0.46 | 0.09% |

---

<br> <sup>1</sup> Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period).

ANNUAL REPORT \| JOHN HANCOCK COLLATERAL TRUST 6

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

Fund's investments

#### AS OF 12-31-22

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Maturity date** | &nbsp;&nbsp;**Yield (%)** | **Par value^** | &nbsp;&nbsp;**Value** |
| **Commercial paper 27.3%** | **Commercial paper 27.3%** | **Commercial paper 27.3%** | **Commercial paper 27.3%** | &nbsp;&nbsp;**$846354091** |
| (Cost $846,861,103) |  |  |  |  |
| Cargill Global Funding PLC | &nbsp;&nbsp;01-03-23 to 01-04-23 | &nbsp;&nbsp;4.331 to 4.332 | 160000000 | &nbsp;&nbsp;&nbsp;&nbsp;159915434 |
| Cummins, Inc. | &nbsp;&nbsp;02-02-23 to 02-06-23 | &nbsp;&nbsp;4.480 to 4.533 | &nbsp;&nbsp;10863000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10817393 |
| Emerson Electric Company | &nbsp;&nbsp;01-20-23 | &nbsp;&nbsp;4.371 | &nbsp;&nbsp;&nbsp;4000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3989962 |
| Georgia Transmission Corp. | &nbsp;&nbsp;03-21-23 | &nbsp;&nbsp;4.609 | &nbsp;&nbsp;&nbsp;8500000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8413555 |
| Gotham Funding Corp. | &nbsp;&nbsp;01-10-23 to 05-03-23 | &nbsp;&nbsp;4.061 to 5.156 | 104394000 | &nbsp;&nbsp;&nbsp;&nbsp;103785866 |
| John Deere Canada ULC | &nbsp;&nbsp;01-17-23 | &nbsp;&nbsp;4.339 | &nbsp;&nbsp;20000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19957000 |
| JP Morgan Securities LLC | &nbsp;&nbsp;01-30-23 to 07-03-23 | &nbsp;&nbsp;2.361 to 5.161 | &nbsp;&nbsp;20500000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20189205 |
| Linde, Inc. | &nbsp;&nbsp;02-08-23 | &nbsp;&nbsp;4.421 | &nbsp;&nbsp;45000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44785000 |
| Macquarie Bank, Ltd. | &nbsp;&nbsp;05-05-23 to 11-15-23 | &nbsp;&nbsp;3.939 to 5.683 | &nbsp;&nbsp;15400000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15128861 |
| Manhattan Asset Funding Company LLC | &nbsp;&nbsp;03-21-23 to 06-20-23 | &nbsp;&nbsp;4.918 to 5.297 | &nbsp;&nbsp;19000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18749556 |
| MUFG Bank, Ltd. | &nbsp;&nbsp;01-25-23 | &nbsp;&nbsp;4.383 | &nbsp;&nbsp;&nbsp;1400000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1395690 |
| National Rural Utilities Cooperative Finance Corp. | &nbsp;&nbsp;01-19-23 to 01-31-23 | &nbsp;&nbsp;4.631 to 4.679 | &nbsp;&nbsp;98000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;97685892 |
| Old Line Funding LLC (SOFR + 0.480%) (A) | &nbsp;&nbsp;06-21-23 | &nbsp;&nbsp;4.846 | &nbsp;&nbsp;21000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21000561 |
| Old Line Funding LLC (SOFR + 0.500%) (A) | &nbsp;&nbsp;04-12-23 | &nbsp;&nbsp;4.867 | &nbsp;&nbsp;10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10000000 |
| Old Line Funding LLC (SOFR + 0.580%) (A) | &nbsp;&nbsp;02-08-23 | &nbsp;&nbsp;4.948 | &nbsp;&nbsp;25000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25000000 |
| Philip Morris International, Inc. | &nbsp;&nbsp;02-02-23 | &nbsp;&nbsp;4.480 | &nbsp;&nbsp;90000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;89617746 |
| PSP Capital, Inc. | &nbsp;&nbsp;01-30-23 to 08-18-23 | &nbsp;&nbsp;4.305 to 5.234 | &nbsp;&nbsp;26375000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25854813 |
| Royal Bank of Canada | &nbsp;&nbsp;03-13-23 | &nbsp;&nbsp;2.507 | &nbsp;&nbsp;10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9906418 |
| Salt River Project Agricultural Improvement & Power District | &nbsp;&nbsp;01-03-23 to 01-11-23 | &nbsp;&nbsp;4.047 to 4.323 | &nbsp;&nbsp;48150000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47958935 |
| State of California | &nbsp;&nbsp;01-18-23 | &nbsp;&nbsp;4.352 | &nbsp;&nbsp;22745000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22734508 |
| Swedbank AB | &nbsp;&nbsp;01-05-23 | &nbsp;&nbsp;4.312 to 4.363 | &nbsp;&nbsp;26650000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26631181 |
| The Trustees of Princeton University | &nbsp;&nbsp;01-25-23 | &nbsp;&nbsp;4.329 | &nbsp;&nbsp;&nbsp;7000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7000000 |
| University of California | &nbsp;&nbsp;01-05-23 to 01-19-23 | &nbsp;&nbsp;4.207 to 4.390 | &nbsp;&nbsp;33000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32905195 |
| Westpac Securities NZ, Ltd. | &nbsp;&nbsp;02-01-23 | &nbsp;&nbsp;3.532 | &nbsp;&nbsp;10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9960492 |
| Yale University | &nbsp;&nbsp;01-17-23 to 01-18-23 | &nbsp;&nbsp;3.272 to 4.186 | &nbsp;&nbsp;13000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12970828 |
| **U.S. Government Agency 18.7%** | **U.S. Government Agency 18.7%** | **U.S. Government Agency 18.7%** | **U.S. Government Agency 18.7%** | &nbsp;&nbsp;**$580290996** |
| (Cost $580,670,865) |  |  |  |  |
| Federal Agricultural Mortgage Corp. | &nbsp;&nbsp;12-18-23 | &nbsp;&nbsp;4.934 | &nbsp;&nbsp;&nbsp;1000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;956048 |
| Federal Farm Credit Bank (U.S. Federal Funds Effective Rate - 0.005%) (A) | &nbsp;&nbsp;06-22-23 | &nbsp;&nbsp;4.418 | &nbsp;&nbsp;&nbsp;4000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4000658 |
| Federal Farm Credit Bank (SOFR + 0.120%) (A) | &nbsp;&nbsp;01-22-24 | &nbsp;&nbsp;4.443 | &nbsp;&nbsp;&nbsp;5000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4999636 |
| Federal Farm Credit Bank (Prime rate - 3.140%) (A) | &nbsp;&nbsp;04-12-24 | &nbsp;&nbsp;4.456 | &nbsp;&nbsp;35000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34982091 |

---

7 JOHN HANCOCK COLLATERAL TRUST \| ANNUAL REPORT SEE NOTES TO FINANCIAL STATEMENTS

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Maturity date** | &nbsp;&nbsp;**Yield (%)** | **Par value^** | &nbsp;&nbsp;**Value** |
| Federal Farm Credit Bank (U.S. Federal Funds Effective Rate + 0.070%) (A) | &nbsp;&nbsp;10-04-24 | &nbsp;&nbsp;4.461 | &nbsp;&nbsp;25000000 | &nbsp;&nbsp;&nbsp;&nbsp;$24999987 |
| Federal Farm Credit Bank (Prime rate - 3.080%) (A) | &nbsp;&nbsp;06-13-24 | &nbsp;&nbsp;4.492 | &nbsp;&nbsp;25000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24996056 |
| Federal Farm Credit Bank (Prime rate - 3.085%) (A) | &nbsp;&nbsp;08-08-24 | &nbsp;&nbsp;4.494 | &nbsp;&nbsp;35000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34985274 |
| Federal Farm Credit Bank (SOFR + 0.140%) (A) | &nbsp;&nbsp;11-07-24 | &nbsp;&nbsp;4.499 | &nbsp;&nbsp;&nbsp;4000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4002050 |
| Federal Farm Credit Bank (SOFR + 0.200%) (A) | &nbsp;&nbsp;12-05-24 | &nbsp;&nbsp;4.560 | &nbsp;&nbsp;&nbsp;3000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3001516 |
| Federal Farm Credit Bank | &nbsp;&nbsp;08-10-23 | &nbsp;&nbsp;4.749 | &nbsp;&nbsp;&nbsp;1000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;973942 |
| Federal Farm Credit Bank (SOFR + 0.060%) (A) | &nbsp;&nbsp;01-13-23 to 04-29-24 | &nbsp;&nbsp;4.380 to 4.480 | &nbsp;&nbsp;30524000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30501731 |
| Federal Home Loan Bank (SOFR + 0.070%) (A) | &nbsp;&nbsp;10-04-23 | &nbsp;&nbsp;4.380 | &nbsp;&nbsp;10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10000000 |
| Federal Home Loan Bank (SOFR + 0.040%) (A) | &nbsp;&nbsp;02-10-23 | &nbsp;&nbsp;4.400 | &nbsp;&nbsp;25000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25000527 |
| Federal Home Loan Bank (SOFR + 0.050%) (A) | &nbsp;&nbsp;06-27-23 | &nbsp;&nbsp;4.409 | &nbsp;&nbsp;30000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30008678 |
| Federal Home Loan Bank (SOFR + 0.055%) (A) | &nbsp;&nbsp;04-03-23 | &nbsp;&nbsp;4.415 | &nbsp;&nbsp;10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10000757 |
| Federal Home Loan Bank (SOFR + 0.030%) (A) | &nbsp;&nbsp;02-28-23 to 03-21-23 | &nbsp;&nbsp;4.390 | &nbsp;&nbsp;33000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;33000623 |
| Federal Home Loan Bank (SOFR + 0.020%) (A) | &nbsp;&nbsp;01-06-23 to 01-11-23 | &nbsp;&nbsp;4.380 | &nbsp;&nbsp;36200000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36199991 |
| Federal Home Loan Bank (SOFR + 0.010%) (A) | &nbsp;&nbsp;01-05-23 to 03-30-23 | &nbsp;&nbsp;4.369 to 4.400 | &nbsp;&nbsp;69000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;69003406 |
| Federal Home Loan Bank | &nbsp;&nbsp;01-03-23 to 12-12-23 | &nbsp;&nbsp;2.559 to 5.014 | 145100000 | &nbsp;&nbsp;&nbsp;&nbsp;144025624 |
| Federal Home Loan Mortgage Corp. | &nbsp;&nbsp;05-19-23 to 08-24-23 | &nbsp;&nbsp;3.239 to 4.692 | &nbsp;&nbsp;15666000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15335019 |
| Federal National Mortgage Association | &nbsp;&nbsp;07-10-23 to 08-10-23 | &nbsp;&nbsp;4.655 to 4.714 | &nbsp;&nbsp;&nbsp;4493000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4379702 |
| Tennessee Valley Authority | &nbsp;&nbsp;01-18-23 | &nbsp;&nbsp;4.175 | &nbsp;&nbsp;35000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34937680 |
| **Corporate interest-bearing obligations 17.9%** | **Corporate interest-bearing obligations 17.9%** | **Corporate interest-bearing obligations 17.9%** | **Corporate interest-bearing obligations 17.9%** | &nbsp;&nbsp;**$554581830** |
| (Cost $554,835,162) |  |  |  |  |
| Apple, Inc. | &nbsp;&nbsp;05-03-23 | &nbsp;&nbsp;2.362 | &nbsp;&nbsp;&nbsp;4000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3967967 |
| Bank of Montreal (SOFR + 0.250%) (A) | &nbsp;&nbsp;03-02-23 | &nbsp;&nbsp;4.613 | &nbsp;&nbsp;19000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18999999 |
| Bank of Montreal (SOFR + 0.260%) (A) | &nbsp;&nbsp;02-14-23 | &nbsp;&nbsp;4.963 | &nbsp;&nbsp;&nbsp;6000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5999928 |
| Bank of Montreal (SOFR + 0.680%) (A) | &nbsp;&nbsp;03-10-23 | &nbsp;&nbsp;4.963 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12005 |
| Bank of Montreal (SOFR + 0.270%) (A) | &nbsp;&nbsp;04-14-23 | &nbsp;&nbsp;5.021 | &nbsp;&nbsp;&nbsp;1021000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1019704 |
| Bank of Montreal (SOFR + 0.265%) (A) | &nbsp;&nbsp;09-15-23 | &nbsp;&nbsp;5.122 | &nbsp;&nbsp;&nbsp;1015000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1012159 |
| Barclays Bank PLC | &nbsp;&nbsp;08-23-23 to 01-12-24 | &nbsp;&nbsp;3.987 to 5.572 | &nbsp;&nbsp;20000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19909255 |
| BNP Paribas SA (B) | &nbsp;&nbsp;03-01-23 | &nbsp;&nbsp;4.974 | &nbsp;&nbsp;&nbsp;2971000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2963694 |

---

SEE NOTES TO FINANCIAL STATEMENTS ANNUAL REPORT \| JOHN HANCOCK COLLATERAL TRUST 8

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Maturity date** | &nbsp;&nbsp;**Yield (%)** | **Par value^** | &nbsp;&nbsp;**Value** |
| BNP Paribas SA (SOFR + 0.720%) (A) | &nbsp;&nbsp;08-04-23 | &nbsp;&nbsp;5.083 | &nbsp;&nbsp;5000000 | &nbsp;&nbsp;$5006838 |
| Canadian Imperial Bank of Commerce | &nbsp;&nbsp;06-22-23 | &nbsp;&nbsp;2.799 | &nbsp;&nbsp;1984000 | &nbsp;&nbsp;&nbsp;&nbsp;1942468 |
| Chariot Funding LLC (SOFR + 0.270%) (A)(B) | &nbsp;&nbsp;01-11-23 | &nbsp;&nbsp;4.633 | 25000000 | &nbsp;&nbsp;25001371 |
| Chariot Funding LLC (B) | &nbsp;&nbsp;01-23-23 | &nbsp;&nbsp;4.907 | 10000000 | &nbsp;&nbsp;10000000 |
| Chariot Funding LLC (SOFR + 0.550%) (A)(B) | &nbsp;&nbsp;02-02-23 | &nbsp;&nbsp;4.917 | 30000000 | &nbsp;&nbsp;30000000 |
| Cooperatieve Rabobank UA | &nbsp;&nbsp;01-10-23 | &nbsp;&nbsp;4.486 | &nbsp;&nbsp;2900000 | &nbsp;&nbsp;&nbsp;&nbsp;2898902 |
| Emerson Electric Company | &nbsp;&nbsp;02-15-23 | &nbsp;&nbsp;1.621 | &nbsp;&nbsp;2500000 | &nbsp;&nbsp;&nbsp;&nbsp;2497193 |
| John Deere Capital Corp. | &nbsp;&nbsp;10-10-23 | &nbsp;&nbsp;4.798 | &nbsp;&nbsp;5890000 | &nbsp;&nbsp;&nbsp;&nbsp;5689902 |
| Jupiter Securitization Company LLC (SOFR + 0.410%) (A)(B) | &nbsp;&nbsp;04-04-23 | &nbsp;&nbsp;4.775 | 25000000 | &nbsp;&nbsp;25000000 |
| Jupiter Securitization Company LLC (SOFR + 0.450%) (A)(B) | &nbsp;&nbsp;04-06-23 | &nbsp;&nbsp;4.817 | 25000000 | &nbsp;&nbsp;24993552 |
| Manhattan Asset Funding Company LLC (SOFR + 0.350%) (A)(B) | &nbsp;&nbsp;04-14-23 | &nbsp;&nbsp;4.715 | 10000000 | &nbsp;&nbsp;10000000 |
| Manhattan Asset Funding Company LLC (SOFR + 0.280%) (A)(B) | &nbsp;&nbsp;01-06-23 to 01-09-23 | &nbsp;&nbsp;4.644 | 50000000 | &nbsp;&nbsp;50000000 |
| National Bank of Canada (SOFR + 0.250%) (A)(B) | &nbsp;&nbsp;02-09-23 | &nbsp;&nbsp;4.817 | &nbsp;&nbsp;8500000 | &nbsp;&nbsp;&nbsp;&nbsp;8500069 |
| National Rural Utilities Cooperative Finance Corp. (SOFR + 0.400%) (A) | &nbsp;&nbsp;08-07-23 | &nbsp;&nbsp;4.852 | &nbsp;&nbsp;3135000 | &nbsp;&nbsp;&nbsp;&nbsp;3124029 |
| Old Line Funding LLC (SOFR + 0.260%) (A)(B) | &nbsp;&nbsp;01-17-23 | &nbsp;&nbsp;4.623 | 25000000 | &nbsp;&nbsp;25000000 |
| Old Line Funding LLC (SOFR + 0.350%) (A)(B) | &nbsp;&nbsp;03-08-23 | &nbsp;&nbsp;4.715 | 25000000 | &nbsp;&nbsp;25000000 |
| Old Line Funding LLC (SOFR + 0.390%) (A)(B) | &nbsp;&nbsp;04-05-23 | &nbsp;&nbsp;4.755 | 25000000 | &nbsp;&nbsp;25000000 |
| PNC Bank NA | &nbsp;&nbsp;06-08-23 | &nbsp;&nbsp;5.066 | &nbsp;&nbsp;3316000 | &nbsp;&nbsp;&nbsp;&nbsp;3295805 |
| Royal Bank of Canada (SOFR + 0.350%) (A)(B) | &nbsp;&nbsp;02-28-23 | &nbsp;&nbsp;4.715 | 10000000 | &nbsp;&nbsp;10000096 |
| Royal Bank of Canada (SOFR + 0.430%) (A)(B) | &nbsp;&nbsp;03-01-23 | &nbsp;&nbsp;4.794 | 10000000 | &nbsp;&nbsp;10003800 |
| Royal Bank of Canada (SOFR + 0.480%) (A)(B) | &nbsp;&nbsp;04-28-23 | &nbsp;&nbsp;4.849 | 15000000 | &nbsp;&nbsp;14992350 |
| Royal Bank of Canada (SOFR + 0.500%) (A)(B) | &nbsp;&nbsp;03-02-23 | &nbsp;&nbsp;4.865 | 10000000 | &nbsp;&nbsp;10002779 |
| Royal Bank of Canada (SOFR + 0.730%) (A)(B) | &nbsp;&nbsp;08-08-23 | &nbsp;&nbsp;5.094 | 15000000 | &nbsp;&nbsp;15018324 |
| The Bank of Nova Scotia | &nbsp;&nbsp;02-01-23 | &nbsp;&nbsp;4.361 | &nbsp;&nbsp;2991000 | &nbsp;&nbsp;&nbsp;&nbsp;2984009 |
| The Bank of Nova Scotia (SOFR + 0.520%) (A)(B) | &nbsp;&nbsp;01-30-23 | &nbsp;&nbsp;4.885 | 25000000 | &nbsp;&nbsp;25007806 |
| The Bank of Nova Scotia (SOFR + 0.550%) (A) | &nbsp;&nbsp;09-15-23 | &nbsp;&nbsp;5.251 | 20000000 | &nbsp;&nbsp;19974482 |

---

9 JOHN HANCOCK COLLATERAL TRUST \| ANNUAL REPORT SEE NOTES TO FINANCIAL STATEMENTS

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Maturity date** | &nbsp;&nbsp;**Yield (%)** | **Par value^** | &nbsp;&nbsp;**Value** |
| The Toronto-Dominion Bank (SOFR + 0.240%) (A) | &nbsp;&nbsp;01-06-23 | &nbsp;&nbsp;4.832 | &nbsp;&nbsp;5234000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$5234128 |
| Thunder Bay Funding LLC (SOFR + 0.390%) (A)(B) | &nbsp;&nbsp;04-11-23 | &nbsp;&nbsp;4.755 | 20000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20000000 |
| Thunder Bay Funding LLC (SOFR + 0.420%) (A)(B) | &nbsp;&nbsp;04-20-23 | &nbsp;&nbsp;4.802 | 25000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24912167 |
| Toyota Motor Credit Corp. | &nbsp;&nbsp;01-11-23 to 03-30-23 | &nbsp;&nbsp;1.424 to 1.811 | 21880000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21838413 |
| Toyota Motor Credit Corp. (SOFR + 0.750%) (A) | &nbsp;&nbsp;12-11-23 | &nbsp;&nbsp;5.112 | &nbsp;&nbsp;5000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5007612 |
| Toyota Motor Credit Corp. (SOFR + 0.200%) (A) | &nbsp;&nbsp;02-13-23 | &nbsp;&nbsp;4.814 | &nbsp;&nbsp;3805000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3804578 |
| UBS AG (SOFR + 0.350%) (A)(B) | &nbsp;&nbsp;01-06-23 | &nbsp;&nbsp;4.714 | 15000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15000630 |
| US Bank NA | &nbsp;&nbsp;01-23-23 | &nbsp;&nbsp;3.966 | &nbsp;&nbsp;1100000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1098973 |
| Westpac Banking Corp. | &nbsp;&nbsp;01-11-23 | &nbsp;&nbsp;4.489 | &nbsp;&nbsp;2868000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2866843 |
| Westpac Banking Corp. (SOFR + 0.550%) (A)(B) | &nbsp;&nbsp;02-22-23 | &nbsp;&nbsp;4.917 | 10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10000000 |
| **Certificate of deposit 8.4%** | **Certificate of deposit 8.4%** | **Certificate of deposit 8.4%** | **Certificate of deposit 8.4%** | &nbsp;&nbsp;**$258489019** |
| (Cost $258,491,251) |  |  |  |  |
| Barclays Bank PLC (SOFR + 0.680%) (A) | &nbsp;&nbsp;04-28-23 | &nbsp;&nbsp;5.049 | 20000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20000000 |
| Barclays Bank PLC (SOFR + 0.780%) (A) | &nbsp;&nbsp;08-18-23 | &nbsp;&nbsp;5.147 | 15000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15009101 |
| BNP Paribas SA (SOFR + 0.590%) (A) | &nbsp;&nbsp;03-02-23 | &nbsp;&nbsp;4.955 | 10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10005792 |
| Canadian Imperial Bank of Commerce (SOFR + 0.500%) (A) | &nbsp;&nbsp;05-08-23 | &nbsp;&nbsp;5.013 | &nbsp;&nbsp;&nbsp;&nbsp;500000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;500467 |
| Canadian Imperial Bank of Commerce | &nbsp;&nbsp;10-06-23 to 11-03-23 | &nbsp;&nbsp;5.180 to 5.647 | 50000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49999083 |
| Commonwealth Bank of Australia (SOFR + 0.200%) (A) | &nbsp;&nbsp;01-20-23 | &nbsp;&nbsp;4.593 | &nbsp;&nbsp;7000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7000222 |
| Commonwealth Bank of Australia (SOFR + 0.460%) (A) | &nbsp;&nbsp;04-03-23 | &nbsp;&nbsp;4.825 | 10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10003229 |
| Goldman Sachs Bank USA (SOFR + 0.300%) (A) | &nbsp;&nbsp;03-09-23 to 03-10-23 | &nbsp;&nbsp;4.664 | 30000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29998578 |
| MUFG Bank, Ltd. (SOFR + 0.560%) (A) | &nbsp;&nbsp;02-02-23 | &nbsp;&nbsp;4.738 | &nbsp;&nbsp;5000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5001597 |
| MUFG Bank, Ltd. (SOFR + 0.590%) (A) | &nbsp;&nbsp;02-10-23 | &nbsp;&nbsp;4.956 | 25000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25009639 |
| Royal Bank of Canada | &nbsp;&nbsp;08-25-23 | &nbsp;&nbsp;4.178 | 10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9925805 |
| Royal Bank of Canada (SOFR + 0.800%) (A) | &nbsp;&nbsp;10-19-23 | &nbsp;&nbsp;5.161 | 10000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10018314 |
| The Bank of Nova Scotia (SOFR + 0.250%) (A) | &nbsp;&nbsp;02-21-23 | &nbsp;&nbsp;4.717 | 15000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14998961 |
| The Bank of Nova Scotia (SOFR + 0.500%) (A) | &nbsp;&nbsp;05-25-23 | &nbsp;&nbsp;4.864 | 25000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25015294 |

---

SEE NOTES TO FINANCIAL STATEMENTS ANNUAL REPORT \| JOHN HANCOCK COLLATERAL TRUST 10

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | &nbsp;&nbsp;**Maturity date** | &nbsp;&nbsp;**Yield (%)** | **Par value^** | &nbsp;&nbsp;**Value** |
| The Toronto-Dominion Bank | &nbsp;&nbsp;02-03-23 to 10-24-23 | &nbsp;&nbsp;4.520 to 5.542 | 25000000 | &nbsp;&nbsp;&nbsp;&nbsp;$25002908 |
| Westpac Banking Corp. (SOFR + 0.190%) (A) | &nbsp;&nbsp;01-12-23 | &nbsp;&nbsp;4.592 | &nbsp;&nbsp;1000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1000029 |
| **U.S. Government 1.3%** | **U.S. Government 1.3%** | **U.S. Government 1.3%** | **U.S. Government 1.3%** | &nbsp;&nbsp;**$39938075** |
| (Cost $39,992,102) |  |  |  |  |
| U.S. Treasury Note (3 month USBMMY - 0.075%) (A) | &nbsp;&nbsp;04-30-24 | &nbsp;&nbsp;4.387 | 20000000 | &nbsp;&nbsp;&nbsp;&nbsp;19961492 |
| U.S. Treasury Note (3 month USBMMY + 0.037%) (A) | &nbsp;&nbsp;07-31-24 | &nbsp;&nbsp;4.531 | 20000000 | &nbsp;&nbsp;&nbsp;&nbsp;19976583 |
| **Time deposits 0.8%** | **Time deposits 0.8%** | **Time deposits 0.8%** | **Time deposits 0.8%** | &nbsp;&nbsp;**$25000000** |
| (Cost $25,000,000) |  |  |  |  |
| Sumitomo Mitsui Banking Corp. | &nbsp;&nbsp;02-10-23 | &nbsp;&nbsp;3.589 | 25000000 | &nbsp;&nbsp;&nbsp;&nbsp;25000000 |

---

---

| | | |
|:---|:---|:---|
|  | **Par value^** | &nbsp;&nbsp;**Value** |
| **Repurchase agreement 23.8%** | **Repurchase agreement 23.8%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$735300000** |
| (Cost $735,300,000) |  |  |
| Repurchase Agreement with State Street Corp. dated 12-30-22 at 1.630% to be repurchased at $25,004,528 on 1-3-23, collateralized by $19,780,600 U.S. Treasury Inflation Indexed Notes, 0.125% due 1-15-23 (valued at $25,500,057) | &nbsp;&nbsp;25000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25000000 |
| Repurchase Agreement with State Street Corp. dated 12-30-22 at 4.260% to be repurchased at $710,636,209 on 1-3-23, collateralized by $42,723,800 U.S. Treasury Inflation Indexed Notes, 0.750% due 7-15-28 (valued at $48,520,699) and $769,901,800 U.S. Treasury Notes, 1.250% - 2.875% due 5-15-28 to 6-30-28 (valued at $675,985,384) | 710300000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;710300000 |
| **Total investments (Cost $3,041,150,483) 98.2%** | **Total investments (Cost $3,041,150,483) 98.2%** | &nbsp;&nbsp;**$3039954011** |
| **Other assets and liabilities, net 1.8%** | **Other assets and liabilities, net 1.8%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**56313569** |
| **Total net assets 100.0%** | **Total net assets 100.0%** | &nbsp;&nbsp;**$3096267580** |

---

---

| | |
|:---|:---|
| The percentage shown for each investment category is the total value of the category as a percentage of the net assets of the fund. | The percentage shown for each investment category is the total value of the category as a percentage of the net assets of the fund. |
| ^All par values are denominated in U.S. dollars unless otherwise indicated. | ^All par values are denominated in U.S. dollars unless otherwise indicated. |
| **Security Abbreviations and Legend** | **Security Abbreviations and Legend** |
| SOFR | Secured Overnight Financing Rate |
| USBMMY | U.S. Treasury Bill Money Market Yield |
| (A) | Variable rate obligation. |
| (B) | These securities are exempt from registration under Rule 144A of the Securities Act of 1933. Such securities may be resold, normally to qualified institutional buyers, in transactions exempt from registration. Rule 144A securities amounted to $416,396,638 or 13.4% of the fund's net assets as of 12-31-22. |

---

At 12-31-22, the aggregate cost of investments for federal income tax purposes was $3,041,150,483. Net unrealized depreciation aggregated to $1,196,472, of which $246,027 related to gross unrealized appreciation and $1,442,499 related to gross unrealized depreciation.

11 JOHN HANCOCK COLLATERAL TRUST \| ANNUAL REPORT SEE NOTES TO FINANCIAL STATEMENTS

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

Financial statements

#### STATEMENT OF ASSETS AND LIABILITIES 12-31-2022

------

---

| | |
|:---|:---|
| **Assets** |  |
| Unaffiliated investments, at value (Cost $2,305,850,483) | &nbsp;&nbsp;&nbsp;&nbsp;$2304654011 |
| Repurchase agreements, at value (Cost $735,300,000) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;735300000 |
| **Total investments, at value (Cost $3,041,150,483)** | &nbsp;&nbsp;&nbsp;&nbsp;**3039954011** |
| Cash | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;61499357 |
| Interest receivable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7156732 |
| Other assets | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;202198 |
| **Total assets** | &nbsp;&nbsp;&nbsp;&nbsp;**3108812298** |
| **Liabilities** |  |
| Distributions payable | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2261661 |
| Payable for investments purchased | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10000000 |
| Payable to affiliates |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Administrative services fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;194141 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transfer agent fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trustees' fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;433 |
| Other liabilities and accrued expenses | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;83483 |
| **Total liabilities** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12544718** |
| **Net assets** | &nbsp;&nbsp;**$3096267580** |
| **Net assets consist of** |  |
| Paid-in capital | &nbsp;&nbsp;&nbsp;&nbsp;$3097449318 |
| Total distributable earnings (loss) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1181738) |
| **Net assets** | &nbsp;&nbsp;**$3096267580** |
| **Net asset value per share** |  |
| Based on 309,746,148 shares of beneficial interest outstanding - unlimited number of shares authorized with no par value | &nbsp;&nbsp;$10.00 |

---

SEE NOTES TO FINANCIAL STATEMENTS ANNUAL REPORT \| JOHN HANCOCK Collateral Trust 12

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

#### STATEMENT OF OPERATIONS For the year ended 12-31-22

------

---

| | |
|:---|:---|
| **Investment income** |  |
| Interest | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$49655168 |
| **Expenses** |  |
| Investment management fees | &nbsp;&nbsp;&nbsp;&nbsp;11149436 |
| Administrative services fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;391086 |
| Transfer agent fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60000 |
| Trustees' fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48162 |
| Custodian fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;175476 |
| Printing and postage | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16120 |
| Professional fees | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;186666 |
| Other | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;102137 |
| **Total expenses** | &nbsp;&nbsp;&nbsp;&nbsp;**12129083** |
| Less expense reductions | &nbsp;&nbsp;&nbsp;&nbsp;(10176157) |
| **Net expenses** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1952926** |
| **Net investment income** | &nbsp;&nbsp;&nbsp;&nbsp;**47702242** |
| **Realized and unrealized gain (loss)** |  |
| **Net realized gain (loss) on** |  |
| Unaffiliated investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(92550) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(92550)** |
| **Change in net unrealized appreciation (depreciation) of** |  |
| Unaffiliated investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1149644) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;**(1149644)** |
| **Net realized and unrealized loss** | &nbsp;&nbsp;&nbsp;&nbsp;**(1242194)** |
| **Increase in net assets from operations** | &nbsp;&nbsp;**$46460048** |

---

13 JOHN HANCOCK Collateral Trust \| ANNUAL REPORT SEE NOTES TO FINANCIAL STATEMENTS

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

#### STATEMENTS OF CHANGES IN NET ASSETS

------

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;**Year ended<br> 12-31-22** | &nbsp;&nbsp;**Year ended<br> 12-31-21** |
| **Increase (decrease) in net assets** |  |  |
| **From operations** |  |  |
| Net investment income | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$47702242 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$594808 |
| Net realized gain (loss) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(92550) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;178253 |
| Change in net unrealized appreciation (depreciation) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1149644) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(338528) |
| **Increase in net assets resulting from operations** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**46460048** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**434533** |
| **Distributions to shareholders** |  |  |
| From earnings | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(47594958) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(824477) |
| **Total distributions** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(47594958)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(824477)** |
| **Fund share transactions** |  |  |
| Shares issued | &nbsp;&nbsp;&nbsp;&nbsp;30223838270 | &nbsp;&nbsp;&nbsp;&nbsp;18830862725 |
| Distributions reinvested | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31375123 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19990 |
| Repurchased | &nbsp;&nbsp;&nbsp;(28415274889) | &nbsp;&nbsp;&nbsp;(18724962126) |
| **Total from fund share transactions** | &nbsp;&nbsp;&nbsp;&nbsp;**1839938504** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**105920589** |
| **Total increase** | &nbsp;&nbsp;&nbsp;&nbsp;**1838803594** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**105530645** |
| **Net assets** |  |  |
| Beginning of year | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1257463986 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1151933341 |
| **End of year** | &nbsp;&nbsp;**$3096267580** | &nbsp;&nbsp;**$1257463986** |
| **Share activity** |  |  |
| **Shares outstanding** |  |  |
| Beginning of year | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;125708716 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;115123545 |
| Shares issued | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3023826612 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1882069724 |
| Distributions reinvested | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3139592 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1998 |
| Shares repurchased | &nbsp;&nbsp;&nbsp;&nbsp;(2842928772) | &nbsp;&nbsp;&nbsp;&nbsp;(1871486551) |
| **End of year** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**309746148** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**125708716** |

---

SEE NOTES TO FINANCIAL STATEMENTS ANNUAL REPORT \| JOHN HANCOCK Collateral Trust 14

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

Financial highlights

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Period ended** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12-31-22** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12-31-21** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12-31-20** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12-31-19** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**12-31-18** |
| **Per share operating performance** |  |  |  |  |  |
| **Net asset value, beginning of period** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.00** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.01** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.01** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.00** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.00** |
| Net investment income<sup>1</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.21 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.01 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.06 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.23 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.20 |
| Net realized and unrealized gain (loss) on investments | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(0.04) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(0.01) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;—<sup>2</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.01 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;—<sup>2</sup> |
| **Total from investment operations** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0.17** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0.00** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0.06** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0.24** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**0.20** |
| **Less distributions** |  |  |  |  |  |
| From net investment income | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(0.17) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(0.01) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(0.06) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(0.23) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(0.20) |
| From net realized gain | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;—<sup>2</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;— |
| **Total distributions** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(0.17)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(0.01)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(0.06)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(0.23)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(0.20)** |
| **Net asset value, end of period** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.00** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.00** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.01** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.01** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**$10.00** |
| Total return (%)<sup>3</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.64 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.04 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.64 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.43 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.00 |
| **Ratios and supplemental data** |  |  |  |  |  |
| Net assets, end of period (in millions) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$3096 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1257 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1152 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2270 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$2265 |
| Ratios (as a percentage of average net assets): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Expenses before reductions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.54 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.55 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.54 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.53 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.53 |
| &nbsp;&nbsp;&nbsp;Expenses including reductions | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.09 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.10 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.09 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.08 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.08 |
| &nbsp;&nbsp;&nbsp;Net investment income | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.11 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.05 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.64 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.28 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.99 |
| Portfolio turnover (%) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;—<sup>4</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;96<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;106<sup>5</sup> | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;70<sup>5</sup> |

---

<sup>1</sup> Based on average daily shares outstanding.

<sup>2</sup> Less than $0.005 per share.

<sup>3</sup> Total returns would have been lower had certain expenses not been reduced during the applicable periods.

<sup>4</sup> Effective November 19, 2021, the fund converted to an institutional prime money market fund, and therefore, portfolio turnover is no longer required.

<sup>5</sup> The calculation of portfolio turnover excludes amounts from all securities whose maturities or expiration dates at the time of acquisition were one year or less, which represents a significant amount of the investments held by the fund.

15 JOHN HANCOCK Collateral Trust \| ANNUAL REPORT SEE NOTES TO FINANCIAL STATEMENTS

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

Notes to financial statements

#### Note 1 — Organization
John Hancock Collateral Trust (the fund) is the sole series of John Hancock Collateral Trust (the Trust), an open-end management investment company organized under the Investment Company Act of 1940, as amended (the 1940 Act). The fund is a privately offered 1940 Act registered institutional prime money market fund and beneficial interests of the fund are not registered under the Securities Act of 1933, as amended. The current investors in the fund are investment companies advised by John Hancock Investment Management LLC, the fund's investment advisor (the Advisor), or its affiliates. The fund serves primarily as an investment vehicle for cash received as collateral by affiliated funds for participation in securities lending. The fund also serves as an investment vehicle for an overnight cash sweep for affiliated funds. The fund has the ability to impose liquidity fees on redemptions and/or temporarily suspend redemptions in the event that fund's weekly liquid assets fall below certain thresholds. This is subject to a determination by fund's Board that such a liquidity fee or redemption gate is in the fund's best interest.

The investment objective of the fund is to seek current income, while maintaining adequate liquidity, safeguarding the return of principal and minimizing risk of default. The fund invests only in U.S. dollar-denominated securities that, at the time of investment, are "eligible securities" as defined by Rule 2a-7 under the 1940 Act. The fund's net asset value (NAV) varies daily.

In accordance with Rule 2a-7, the fund is designated as an institutional prime money market fund and is required to utilize current market-based prices to value its portfolio securities and transact at a floating net asset value (NAV) that uses four-decimal-place precision ($10.0000). Because the share price of the fund will fluctuate, when a shareholder sells its shares, they may be worth more or less than what the shareholder originally paid for them.

#### Note 2 — Significant accounting policies
The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (US GAAP), which require management to make certain estimates and assumptions as of the date of the financial statements. Actual results could differ from those estimates and those differences could be significant. The fund qualifies as an investment company under Topic 946 of Accounting Standards Codification of US GAAP.

Events or transactions occurring after the end of the fiscal period through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The following summarizes the significant accounting policies of the fund:

**Security valuation. Investments are stated at value as of the scheduled close of regular trading on the New York Stock Exchange (NYSE), normally at 4:00 P.M., Eastern Time. In case of emergency or other disruption resulting in the NYSE not opening for trading or the NYSE closing at a time other than the regularly scheduled close, the net asset value (NAV) may be determined as of the regularly scheduled close of the NYSE pursuant to the Advisor's Valuation Policies and Procedures.**

In order to value the securities, the fund uses the following valuation techniques: Debt obligations are typically valued based on evaluated prices provided by an independent pricing vendor. Independent pricing vendors utilize matrix pricing, which takes into account factors such as institutional-size trading in similar groups of securities, yield, quality, coupon rate, maturity, type of issue, trading characteristics and other market data, as well as broker supplied prices.

Other portfolio securities and assets, for which reliable market quotations are not readily available, are valued at fair value as determined in good faith by the Pricing Committee following procedures established by the Advisor and adopted by the Board of Trustees. The frequency with which these fair valuation procedures are used cannot be predicted and fair value of securities may differ significantly from the value that would have been used had a ready market for such securities existed.

ANNUAL REPORT \| JOHN HANCOCK Collateral Trust 16

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

The fund uses a three tier hierarchy to prioritize the pricing assumptions, referred to as inputs, used in valuation techniques to measure fair value. Level 1 includes securities valued using quoted prices in active markets for identical securities, including registered investment companies. Level 2 includes securities valued using other significant observable inputs. Observable inputs may include quoted prices for similar securities, interest rates, prepayment speeds and credit risk. Prices for securities valued using these inputs are received from independent pricing vendors and brokers and are based on an evaluation of the inputs described. Level 3 includes securities valued using significant unobservable inputs when market prices are not readily available or reliable, including the Advisor's assumptions in determining the fair value of investments. Factors used in determining value may include market or issuer specific events or trends, changes in interest rates and credit quality. The inputs or methodology used for valuing securities are not necessarily an indication of the risks associated with investing in those securities. Changes in valuation techniques and related inputs may result in transfers into or out of an assigned level within the disclosure hierarchy.

As of December 31, 2022, all investments are categorized as Level 2 under the hierarchy described above.

**Repurchase agreements. The fund may enter into repurchase agreements. When the fund enters into a repurchase agreement, it receives collateral that is held in a segregated account by the fund's custodian, or for tri-party repurchase agreements, collateral is held at a third-party custodian bank in a segregated account for the benefit of the fund. The collateral amount is marked-to-market and monitored on a daily basis to ensure that the collateral held is in an amount not less than the principal amount of the repurchase agreement plus any accrued interest. Collateral received by the fund for repurchase agreements is disclosed in the Fund's investments as part of the caption related to the repurchase agreement.**

Repurchase agreements are typically governed by the terms and conditions of the Master Repurchase Agreement and/or Global Master Repurchase Agreement (collectively, MRA). Upon an event of default, the non-defaulting party may close out all transactions traded under the MRA and net amounts owed. Absent an event of default, assets and liabilities resulting from repurchase agreements are not offset in the Statement of assets and liabilities. In the event of a default by the counterparty, realization of the collateral proceeds could be delayed, during which time the collateral value may decline or the counterparty may have insufficient assets to pay claims resulting from close-out of the transactions.

**Security transactions and related investment income. Investment security transactions are accounted for on a trade date plus one basis for daily NAV calculations. However, for financial reporting purposes, investment transactions are reported on trade date. Interest income is accrued as earned. Interest income includes coupon interest and amortization/accretion of premiums/discounts on debt securities. Debt obligations may be placed in a non-accrual status and related interest income may be reduced by stopping current accruals and writing off interest receivable when the collection of all or a portion of interest has become doubtful. Gains and losses on securities sold are determined on the basis of identified cost and may include proceeds from litigation.**

**Overdraft. The fund may have the ability to borrow from banks for temporary or emergency purposes, including meeting redemption requests that otherwise might require the untimely sale of securities. Pursuant to the fund's custodian agreement, the custodian may loan money to the fund to make properly authorized payments. The fund is obligated to repay the custodian for any overdraft, including any related costs or expenses. The custodian may have a lien, security interest or security entitlement in any fund property that is not otherwise segregated or pledged, to the extent of any overdraft, and to the maximum extent permitted by law.**

**Line of credit. The fund and other affiliated funds have entered into a syndicated line of credit agreement with Citibank, N.A. as the administrative agent that enables them to participate in a $1 billion unsecured committed line of credit. Excluding commitments designated for a certain fund and subject to the needs of all other affiliated funds, the fund can borrow up to an aggregate commitment amount of $750 million, subject to asset coverage and other limitations as specified in the agreement. A commitment fee payable at the end of each calendar quarter, based on the average daily unused portion of the line of credit, is charged to each participating fund**

17 JOHN HANCOCK Collateral Trust \| ANNUAL REPORT

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

based on a combination of fixed and asset-based allocations and is reflected in Other expenses on the Statement of operations. For the year ended December 31, 2022, the fund had no borrowings under the line of credit. Commitment fees for the year ended December 31, 2022 were $9,829.

**Expenses. Within the John Hancock group of funds complex, expenses that are directly attributable to an individual fund are allocated to such fund. Expenses that are not readily attributable to a specific fund are allocated among all funds in an equitable manner, taking into consideration, among other things, the nature and type of expense and the fund's relative net assets. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.**

**Federal income taxes. The fund intends to continue to qualify as a regulated investment company by complying with the applicable provisions of the Internal Revenue Code and will not be subject to federal income tax on taxable income that is distributed to shareholders. Therefore, no federal income tax provision is required.**

For federal income tax purposes, as of December 31, 2022, the fund has a short-term capital loss carryforward of $92,550 available to offset future net realized capital gains. This carryforward does not expire.

As of December 31, 2022, the fund had no uncertain tax positions that would require financial statement recognition, derecognition or disclosure. The fund's federal tax returns are subject to examination by the Internal Revenue Service for a period of three years.

**Distribution of income and gains. Distributions to shareholders from net investment income and net realized gains, if any, are recorded on the ex-date. The fund generally declares dividends daily and pays them monthly. Capital gain distributions, if any, are typically distributed annually.**

The tax character of distributions for the years ended December 31, 2022 and 2021 was as follows:

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;**December 31, 2022** | &nbsp;&nbsp;&nbsp;**December 31, 2021** |
| Ordinary income | &nbsp;&nbsp;$47594958 | &nbsp;&nbsp;$824477 |

---

As of December 31, 2022, the components of distributable earnings on a tax basis consisted of $107,284 of undistributed ordinary income.

Such distributions and distributable earnings, on a tax basis, are determined in conformity with income tax regulations, which may differ from US GAAP. Distributions in excess of tax basis earnings and profits, if any, are reported in the fund's financial statements as a return of capital.

Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Temporary book-tax differences, if any, will reverse in a subsequent period. The fund had no material book-tax differences at December 31, 2022.

#### Note 3 — Guarantees and indemnifications
Under the Trust's organizational documents, its Officers and Trustees are indemnified against certain liabilities arising out of the performance of their duties to the Trust, including the fund. Additionally, in the normal course of business, the fund enters into contracts with service providers that contain general indemnification clauses. The fund's maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the fund that have not yet occurred. The risk of material loss from such claims is considered remote.

#### Note 4 — Fees and transactions with affiliates
The Advisor serves as investment advisor for the fund. John Hancock Investment Management Distributors LLC (the Placement Agent), performs services related to the offering and sale of shares of the fund. The Advisor and the Placement Agent are indirect, principally owned subsidiaries of John Hancock Life Insurance Company (U.S.A.), which in turn is a subsidiary of Manulife Financial Corporation (MFC).

ANNUAL REPORT \| JOHN HANCOCK Collateral Trust 18

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

**Management fee. The fund has an investment management agreement with the Advisor under which the fund pays a daily management fee to the Advisor equivalent on an annual basis to the sum of: (a) 0.500% of the first $1.5 billion of the fund's average net assets and (b) 0.480% of the fund's average net assets in excess of $1.5 billion. The Advisor has a subadvisory agreement with Manulife Investment Management (US) LLC, an indirectly owned subsidiary of MFC and an affiliate of the Advisor. The fund is not responsible for payment of the subadvisory fees.**

The Advisor has contractually agreed to waive its management fee by 0.45% of the fund's average net assets. The expense waiver will remain in effect until April 30, 2023, unless renewed by mutual agreement of the fund and the Advisor based upon a determination that this is appropriate under the circumstances at the time and may be terminated at any time thereafter.

The expense reductions described above amounted to $10,176,157 for the year ended December 31, 2022.

Expenses waived or reimbursed in the current fiscal period are not subject to recapture in the future fiscal periods.

The investment management fees, including the impact of the waivers and reimbursements as described above, incurred for the year ended December 31, 2022, were equivalent to a net annual effective rate of 0.04% of the fund's average daily net assets.

**Administrative services fees. Pursuant to a service agreement, the fund reimburses the Advisor for all expenses associated with providing the administrative, financial, legal, compliance, accounting and recordkeeping services to the fund, including the preparation of all tax returns, periodic reports to shareholders and regulatory reports, among other services. These administrative services fees incurred, for the year ended December 31, 2022, amounted to an annual rate of 0.02% of the fund's average daily net assets.**

**Transfer agent fees. The fund has a transfer agent agreement with John Hancock Signature Services, Inc. (the Transfer Agent), an affiliate of the Advisor. Monthly, the fund pays the Transfer Agent a fee which is based on an annual rate of $60,000. The fund also pays certain out-of-pocket expenses to the Transfer Agent.**

**Trustee expenses. The fund compensates each Trustee who is not an employee of the Advisor or its affiliates. The costs of paying Trustee compensation and expenses are allocated to the fund based on its net assets relative to other funds within the John Hancock group of funds complex.**

19 JOHN HANCOCK Collateral Trust \| ANNUAL REPORT

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

#### Report of Independent Registered Public Accounting Firm

------

#### To the Board of Trustees and Shareholders of John Hancock Collateral Trust

#### Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the fund's investments, of John Hancock Collateral Trust (the "Fund") as of December 31, 2022, the related statement of operations for the year ended December 31, 2022, the statements of changes in net assets for each of the two years in the period ended December 31, 2022, including the related notes, and the financial highlights for each of the five years in the period ended December 31, 2022 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of December 31, 2022, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended December 31, 2022 and the financial highlights for each of the five years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.

#### Basis for Opinion
These financial statements are the responsibility of the Fund's management. Our responsibility is to express an opinion on the Fund's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

February 21, 2023

We have served as the auditor of one or more investment companies in the John Hancock group of funds since 1988.

ANNUAL REPORT \| JOHN HANCOCK COLLATERAL TRUST 20

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

#### SHAREHOLDER MEETING

------

(Unaudited)

The fund held a Special Joint Meeting of Shareholders on Friday, September 9, 2022. The following proposal was considered by the shareholders:

#### Proposal: To elect eight Trustees as members of the Board of Trustees of the Trust.
THE PROPOSAL <u>PASSED</u> ON September 9, 2022.

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;**Total votes<br> for the nominee** | &nbsp;&nbsp;&nbsp;**Total votes withheld<br> from the nominee** |
| **Independent Trustees** |  |  |
| James R. Boyle | &nbsp;&nbsp;115788040.000 | &nbsp;&nbsp;0.000 |
| Noni L. Ellison | &nbsp;&nbsp;115788040.000 | &nbsp;&nbsp;0.000 |
| Dean C. Garfield | &nbsp;&nbsp;115788040.000 | &nbsp;&nbsp;0.000 |
| Patricia Lizarraga | &nbsp;&nbsp;115788040.000 | &nbsp;&nbsp;0.000 |
| Frances G. Rathke | &nbsp;&nbsp;115788040.000 | &nbsp;&nbsp;0.000 |

---

---

| | | |
|:---|:---|:---|
| **Non-Independent Trustees** |  |  |
| Andrew G. Arnott | &nbsp;&nbsp;115,788,040.000 | &nbsp;&nbsp;0.000 |
| Marianne Harrison | &nbsp;&nbsp;115,788,040.000 | &nbsp;&nbsp;0.000 |
| Paul Lorentz | &nbsp;&nbsp;115,788,040.000 | &nbsp;&nbsp;0.000 |

---

21 JOHN HANCOCK COLLATERAL TRUST \| ANNUAL REPORT

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

Trustees and Officers

This chart provides information about the Trustees and Officers who oversee your John Hancock fund. Officers elected by the Trustees manage the day-to-day operations of the fund and execute policies formulated by the Trustees.

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;**Independent Trustees** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Name, year of birth<br> Position(s) held with Trust<br> Principal occupation(s) and other<br> directorships during past 5 years** | &nbsp;&nbsp;&nbsp;**Trustee<br> of the<br> Trust<br> since<sup>1</sup>** | &nbsp;&nbsp;&nbsp;**Number of John<br> Hancock funds<br> overseen by<br> Trustee** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Hassell H. McClellan, Born: 1945** | &nbsp;&nbsp;&nbsp;**2015** | &nbsp;&nbsp;&nbsp;**186** |
| &nbsp;&nbsp;&nbsp;*Trustee and Chairperson of the Board* |  |  |
| &nbsp;&nbsp;&nbsp;Director/Trustee, Virtus Funds (2008-2020); Director, The Barnes Group (2010-2021); Associate Professor, The Wallace E. Carroll School of Management, Boston College (retired 2013). Trustee (since 2005) and Chairperson of the Board (since 2017) of various trusts within the John Hancock Fund Complex. | &nbsp;&nbsp;&nbsp;Director/Trustee, Virtus Funds (2008-2020); Director, The Barnes Group (2010-2021); Associate Professor, The Wallace E. Carroll School of Management, Boston College (retired 2013). Trustee (since 2005) and Chairperson of the Board (since 2017) of various trusts within the John Hancock Fund Complex. | &nbsp;&nbsp;&nbsp;Director/Trustee, Virtus Funds (2008-2020); Director, The Barnes Group (2010-2021); Associate Professor, The Wallace E. Carroll School of Management, Boston College (retired 2013). Trustee (since 2005) and Chairperson of the Board (since 2017) of various trusts within the John Hancock Fund Complex. |
| &nbsp;&nbsp;&nbsp;&nbsp;**James R. Boyle, Born: 1959** | &nbsp;&nbsp;&nbsp;**2015** | &nbsp;&nbsp;&nbsp;**183** |
| &nbsp;&nbsp;&nbsp;*Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Board Member, United of Omaha Life Insurance Company (since 2022). Board Member, Mutual of Omaha Investor Services, Inc. (since 2022). Foresters Financial, Chief Executive Officer (2018–2022) and board member (2017–2022). Manulife Financial and John Hancock, more than 20 years, retiring in 2012 as Chief Executive Officer, John Hancock and Senior Executive Vice President, Manulife Financial. Trustee of various trusts within the John Hancock Fund Complex (2005–2014 and since 2015). | &nbsp;&nbsp;&nbsp;Board Member, United of Omaha Life Insurance Company (since 2022). Board Member, Mutual of Omaha Investor Services, Inc. (since 2022). Foresters Financial, Chief Executive Officer (2018–2022) and board member (2017–2022). Manulife Financial and John Hancock, more than 20 years, retiring in 2012 as Chief Executive Officer, John Hancock and Senior Executive Vice President, Manulife Financial. Trustee of various trusts within the John Hancock Fund Complex (2005–2014 and since 2015). | &nbsp;&nbsp;&nbsp;Board Member, United of Omaha Life Insurance Company (since 2022). Board Member, Mutual of Omaha Investor Services, Inc. (since 2022). Foresters Financial, Chief Executive Officer (2018–2022) and board member (2017–2022). Manulife Financial and John Hancock, more than 20 years, retiring in 2012 as Chief Executive Officer, John Hancock and Senior Executive Vice President, Manulife Financial. Trustee of various trusts within the John Hancock Fund Complex (2005–2014 and since 2015). |
| &nbsp;&nbsp;&nbsp;&nbsp;**William H. Cunningham,<sup>2</sup> Born: 1944** | &nbsp;&nbsp;&nbsp;**2015** | &nbsp;&nbsp;&nbsp;**184** |
| &nbsp;&nbsp;&nbsp;*Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Professor, University of Texas, Austin, Texas (since 1971); former Chancellor, University of Texas System and former President of the University of Texas, Austin, Texas; Director (since 2006), Lincoln National Corporation (insurance); Director, Southwest Airlines (since 2000). Trustee of various trusts within the John Hancock Fund Complex (since 1986). | &nbsp;&nbsp;&nbsp;Professor, University of Texas, Austin, Texas (since 1971); former Chancellor, University of Texas System and former President of the University of Texas, Austin, Texas; Director (since 2006), Lincoln National Corporation (insurance); Director, Southwest Airlines (since 2000). Trustee of various trusts within the John Hancock Fund Complex (since 1986). | &nbsp;&nbsp;&nbsp;Professor, University of Texas, Austin, Texas (since 1971); former Chancellor, University of Texas System and former President of the University of Texas, Austin, Texas; Director (since 2006), Lincoln National Corporation (insurance); Director, Southwest Airlines (since 2000). Trustee of various trusts within the John Hancock Fund Complex (since 1986). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Noni L. Ellison,<sup>\*</sup> Born: 1971** | &nbsp;&nbsp;&nbsp;**2022** | &nbsp;&nbsp;&nbsp;**183** |
| &nbsp;&nbsp;&nbsp;*Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Senior Vice President, General Counsel & Corporate Secretary, Tractor Supply Company (rural lifestyle retailer) (since 2021); General Counsel, Chief Compliance Officer & Corporate Secretary, Carestream Dental, L.L.C.(2017–2021); Associate General Counsel & Assistant Corporate Secretary, W.W. Grainger, Inc. (global industrial supplier) (2015–2017); Board Member, Goodwill of North Georgia, 2018 (FY2019)–2020 (FY2021); Board Member, Howard University School of Law Board of Visitors (since 2021); Board Member, University of Chicago Law School Board of Visitors (since 2016); Board member, Children's Healthcare of Atlanta Foundation Board (2021–present). Trustee of various trusts within the John Hancock Fund Complex (since 2022). | &nbsp;&nbsp;&nbsp;Senior Vice President, General Counsel & Corporate Secretary, Tractor Supply Company (rural lifestyle retailer) (since 2021); General Counsel, Chief Compliance Officer & Corporate Secretary, Carestream Dental, L.L.C.(2017–2021); Associate General Counsel & Assistant Corporate Secretary, W.W. Grainger, Inc. (global industrial supplier) (2015–2017); Board Member, Goodwill of North Georgia, 2018 (FY2019)–2020 (FY2021); Board Member, Howard University School of Law Board of Visitors (since 2021); Board Member, University of Chicago Law School Board of Visitors (since 2016); Board member, Children's Healthcare of Atlanta Foundation Board (2021–present). Trustee of various trusts within the John Hancock Fund Complex (since 2022). | &nbsp;&nbsp;&nbsp;Senior Vice President, General Counsel & Corporate Secretary, Tractor Supply Company (rural lifestyle retailer) (since 2021); General Counsel, Chief Compliance Officer & Corporate Secretary, Carestream Dental, L.L.C.(2017–2021); Associate General Counsel & Assistant Corporate Secretary, W.W. Grainger, Inc. (global industrial supplier) (2015–2017); Board Member, Goodwill of North Georgia, 2018 (FY2019)–2020 (FY2021); Board Member, Howard University School of Law Board of Visitors (since 2021); Board Member, University of Chicago Law School Board of Visitors (since 2016); Board member, Children's Healthcare of Atlanta Foundation Board (2021–present). Trustee of various trusts within the John Hancock Fund Complex (since 2022). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Grace K. Fey, Born: 1946** | &nbsp;&nbsp;&nbsp;**2015** | &nbsp;&nbsp;&nbsp;**186** |
| &nbsp;&nbsp;&nbsp;*Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Chief Executive Officer, Grace Fey Advisors (since 2007); Director and Executive Vice President, Frontier Capital Management Company (1988–2007); Director, Fiduciary Trust (since 2009). Trustee of various trusts within the John Hancock Fund Complex (since 2008). | &nbsp;&nbsp;&nbsp;Chief Executive Officer, Grace Fey Advisors (since 2007); Director and Executive Vice President, Frontier Capital Management Company (1988–2007); Director, Fiduciary Trust (since 2009). Trustee of various trusts within the John Hancock Fund Complex (since 2008). | &nbsp;&nbsp;&nbsp;Chief Executive Officer, Grace Fey Advisors (since 2007); Director and Executive Vice President, Frontier Capital Management Company (1988–2007); Director, Fiduciary Trust (since 2009). Trustee of various trusts within the John Hancock Fund Complex (since 2008). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Dean C. Garfield,<sup>\*</sup> Born: 1968** | &nbsp;&nbsp;&nbsp;**2022** | &nbsp;&nbsp;&nbsp;**183** |
| &nbsp;&nbsp;&nbsp;*Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Vice President, Netflix, Inc. (since 2019); President & Chief Executive Officer, Information Technology Industry Council (2009–2019); NYU School of Law Board of Trustees (since 2021); Member, U.S. Department of Transportation, Advisory Committee on Automation (since 2021); President of the United States Trade Advisory Council (2010–2018); Board Member, College for Every Student (2017–2021); Board Member, The Seed School of Washington, D.C. (2012–2017). Trustee of various trusts within the John Hancock Fund Complex (since 2022). | &nbsp;&nbsp;&nbsp;Vice President, Netflix, Inc. (since 2019); President & Chief Executive Officer, Information Technology Industry Council (2009–2019); NYU School of Law Board of Trustees (since 2021); Member, U.S. Department of Transportation, Advisory Committee on Automation (since 2021); President of the United States Trade Advisory Council (2010–2018); Board Member, College for Every Student (2017–2021); Board Member, The Seed School of Washington, D.C. (2012–2017). Trustee of various trusts within the John Hancock Fund Complex (since 2022). | &nbsp;&nbsp;&nbsp;Vice President, Netflix, Inc. (since 2019); President & Chief Executive Officer, Information Technology Industry Council (2009–2019); NYU School of Law Board of Trustees (since 2021); Member, U.S. Department of Transportation, Advisory Committee on Automation (since 2021); President of the United States Trade Advisory Council (2010–2018); Board Member, College for Every Student (2017–2021); Board Member, The Seed School of Washington, D.C. (2012–2017). Trustee of various trusts within the John Hancock Fund Complex (since 2022). |

---

ANNUAL REPORT \| JOHN HANCOCK COLLATERAL TRUST 22

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;**Independent Trustees (continued)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Name, year of birth<br> Position(s) held with Trust<br> Principal occupation(s) and other<br> directorships during past 5 years** | &nbsp;&nbsp;&nbsp;**Trustee<br> of the<br> Trust<br> since<sup>1</sup>** | &nbsp;&nbsp;&nbsp;**Number of John<br> Hancock funds<br> overseen by<br> Trustee** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Deborah C. Jackson, Born: 1952** | &nbsp;&nbsp;&nbsp;**2015** | &nbsp;&nbsp;&nbsp;**185** |
| &nbsp;&nbsp;&nbsp;*Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;President, Cambridge College, Cambridge, Massachusetts (since 2011); Board of Directors, Amwell Corporation (since 2020); Board of Directors, Massachusetts Women's Forum (2018-2020); Board of Directors, National Association of Corporate Directors/New England (2015-2020); Chief Executive Officer, American Red Cross of Massachusetts Bay (2002–2011); Board of Directors of Eastern Bank Corporation (since 2001); Board of Directors of Eastern Bank Charitable Foundation (since 2001); Board of Directors of Boston Stock Exchange (2002–2008); Board of Directors of Harvard Pilgrim Healthcare (health benefits company) (2007–2011). Trustee of various trusts within the John Hancock Fund Complex (since 2008). | &nbsp;&nbsp;&nbsp;President, Cambridge College, Cambridge, Massachusetts (since 2011); Board of Directors, Amwell Corporation (since 2020); Board of Directors, Massachusetts Women's Forum (2018-2020); Board of Directors, National Association of Corporate Directors/New England (2015-2020); Chief Executive Officer, American Red Cross of Massachusetts Bay (2002–2011); Board of Directors of Eastern Bank Corporation (since 2001); Board of Directors of Eastern Bank Charitable Foundation (since 2001); Board of Directors of Boston Stock Exchange (2002–2008); Board of Directors of Harvard Pilgrim Healthcare (health benefits company) (2007–2011). Trustee of various trusts within the John Hancock Fund Complex (since 2008). | &nbsp;&nbsp;&nbsp;President, Cambridge College, Cambridge, Massachusetts (since 2011); Board of Directors, Amwell Corporation (since 2020); Board of Directors, Massachusetts Women's Forum (2018-2020); Board of Directors, National Association of Corporate Directors/New England (2015-2020); Chief Executive Officer, American Red Cross of Massachusetts Bay (2002–2011); Board of Directors of Eastern Bank Corporation (since 2001); Board of Directors of Eastern Bank Charitable Foundation (since 2001); Board of Directors of Boston Stock Exchange (2002–2008); Board of Directors of Harvard Pilgrim Healthcare (health benefits company) (2007–2011). Trustee of various trusts within the John Hancock Fund Complex (since 2008). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Patricia Lizarraga,<sup>2,\*</sup> Born: 1966** | &nbsp;&nbsp;&nbsp;**2022** | &nbsp;&nbsp;&nbsp;**183** |
| &nbsp;&nbsp;&nbsp;*Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Founder, Chief Executive Officer, Hypatia Capital Group (advisory and asset management company) (since 2007); Independent Director, Audit Committee Chair, and Risk Committee Member, Credicorp, Ltd. (since 2017); Independent Director, Audit Committee Chair, Banco De Credito Del Peru (since 2017); Trustee, Museum of Art of Lima (since 2009). Trustee of various trusts within the John Hancock Fund Complex (since 2022). | &nbsp;&nbsp;&nbsp;Founder, Chief Executive Officer, Hypatia Capital Group (advisory and asset management company) (since 2007); Independent Director, Audit Committee Chair, and Risk Committee Member, Credicorp, Ltd. (since 2017); Independent Director, Audit Committee Chair, Banco De Credito Del Peru (since 2017); Trustee, Museum of Art of Lima (since 2009). Trustee of various trusts within the John Hancock Fund Complex (since 2022). | &nbsp;&nbsp;&nbsp;Founder, Chief Executive Officer, Hypatia Capital Group (advisory and asset management company) (since 2007); Independent Director, Audit Committee Chair, and Risk Committee Member, Credicorp, Ltd. (since 2017); Independent Director, Audit Committee Chair, Banco De Credito Del Peru (since 2017); Trustee, Museum of Art of Lima (since 2009). Trustee of various trusts within the John Hancock Fund Complex (since 2022). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Steven R. Pruchansky, Born: 1944** | &nbsp;&nbsp;&nbsp;**2015** | &nbsp;&nbsp;&nbsp;**183** |
| &nbsp;&nbsp;&nbsp;*Trustee and Vice Chairperson of the Board* |  |  |
| &nbsp;&nbsp;&nbsp;Managing Director, Pru Realty (since 2017); Chairman and Chief Executive Officer, Greenscapes of Southwest Florida, Inc. (2014-2020); Director and President, Greenscapes of Southwest Florida, Inc. (until 2000); Member, Board of Advisors, First American Bank (until 2010); Managing Director, Jon James, LLC (real estate) (since 2000); Partner, Right Funding, LLC (2014-2017); Director, First Signature Bank & Trust Company (until 1991); Director, Mast Realty Trust (until 1994); President, Maxwell Building Corp. (until 1991). Trustee (since 1992), Chairperson of the Board (2011–2012), and Vice Chairperson of the Board (since 2012) of various trusts within the John Hancock Fund Complex. | &nbsp;&nbsp;&nbsp;Managing Director, Pru Realty (since 2017); Chairman and Chief Executive Officer, Greenscapes of Southwest Florida, Inc. (2014-2020); Director and President, Greenscapes of Southwest Florida, Inc. (until 2000); Member, Board of Advisors, First American Bank (until 2010); Managing Director, Jon James, LLC (real estate) (since 2000); Partner, Right Funding, LLC (2014-2017); Director, First Signature Bank & Trust Company (until 1991); Director, Mast Realty Trust (until 1994); President, Maxwell Building Corp. (until 1991). Trustee (since 1992), Chairperson of the Board (2011–2012), and Vice Chairperson of the Board (since 2012) of various trusts within the John Hancock Fund Complex. | &nbsp;&nbsp;&nbsp;Managing Director, Pru Realty (since 2017); Chairman and Chief Executive Officer, Greenscapes of Southwest Florida, Inc. (2014-2020); Director and President, Greenscapes of Southwest Florida, Inc. (until 2000); Member, Board of Advisors, First American Bank (until 2010); Managing Director, Jon James, LLC (real estate) (since 2000); Partner, Right Funding, LLC (2014-2017); Director, First Signature Bank & Trust Company (until 1991); Director, Mast Realty Trust (until 1994); President, Maxwell Building Corp. (until 1991). Trustee (since 1992), Chairperson of the Board (2011–2012), and Vice Chairperson of the Board (since 2012) of various trusts within the John Hancock Fund Complex. |
| &nbsp;&nbsp;&nbsp;&nbsp;**Frances G. Rathke,<sup>2</sup> Born: 1960** | &nbsp;&nbsp;&nbsp;**2020** | &nbsp;&nbsp;&nbsp;**183** |
| &nbsp;&nbsp;&nbsp;*Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Director, Audit Committee Chair, Oatly Group AB (plant-based drink company) (since 2021); Director, Audit Committee Chair and Compensation Committee Member, Green Mountain Power Corporation (since 2016); Director, Treasurer and Finance & Audit Committee Chair, Flynn Center for Performing Arts (since 2016); Director and Audit Committee Chair, Planet Fitness (since 2016); Chief Financial Officer and Treasurer, Keurig Green Mountain, Inc. (2003-retired 2015). Trustee of various trusts within the John Hancock Fund Complex (since 2020). | &nbsp;&nbsp;&nbsp;Director, Audit Committee Chair, Oatly Group AB (plant-based drink company) (since 2021); Director, Audit Committee Chair and Compensation Committee Member, Green Mountain Power Corporation (since 2016); Director, Treasurer and Finance & Audit Committee Chair, Flynn Center for Performing Arts (since 2016); Director and Audit Committee Chair, Planet Fitness (since 2016); Chief Financial Officer and Treasurer, Keurig Green Mountain, Inc. (2003-retired 2015). Trustee of various trusts within the John Hancock Fund Complex (since 2020). | &nbsp;&nbsp;&nbsp;Director, Audit Committee Chair, Oatly Group AB (plant-based drink company) (since 2021); Director, Audit Committee Chair and Compensation Committee Member, Green Mountain Power Corporation (since 2016); Director, Treasurer and Finance & Audit Committee Chair, Flynn Center for Performing Arts (since 2016); Director and Audit Committee Chair, Planet Fitness (since 2016); Chief Financial Officer and Treasurer, Keurig Green Mountain, Inc. (2003-retired 2015). Trustee of various trusts within the John Hancock Fund Complex (since 2020). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Gregory A. Russo, Born: 1949** | &nbsp;&nbsp;&nbsp;**2015** | &nbsp;&nbsp;&nbsp;**183** |
| &nbsp;&nbsp;&nbsp;*Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Director and Audit Committee Chairman (2012-2020), and Member, Audit Committee and Finance Committee (2011-2020), NCH Healthcare System, Inc. (holding company for multi-entity healthcare system); Director and Member (2012-2018), and Finance Committee Chairman (2014-2018), The Moorings, Inc. (nonprofit continuing care community); Global Vice Chairman, Risk & Regulatory Matters, KPMG LLP (KPMG) (2002–2006); Vice Chairman, Industrial Markets, KPMG (1998–2002). Trustee of various trusts within the John Hancock Fund Complex (since 2008). | &nbsp;&nbsp;&nbsp;Director and Audit Committee Chairman (2012-2020), and Member, Audit Committee and Finance Committee (2011-2020), NCH Healthcare System, Inc. (holding company for multi-entity healthcare system); Director and Member (2012-2018), and Finance Committee Chairman (2014-2018), The Moorings, Inc. (nonprofit continuing care community); Global Vice Chairman, Risk & Regulatory Matters, KPMG LLP (KPMG) (2002–2006); Vice Chairman, Industrial Markets, KPMG (1998–2002). Trustee of various trusts within the John Hancock Fund Complex (since 2008). | &nbsp;&nbsp;&nbsp;Director and Audit Committee Chairman (2012-2020), and Member, Audit Committee and Finance Committee (2011-2020), NCH Healthcare System, Inc. (holding company for multi-entity healthcare system); Director and Member (2012-2018), and Finance Committee Chairman (2014-2018), The Moorings, Inc. (nonprofit continuing care community); Global Vice Chairman, Risk & Regulatory Matters, KPMG LLP (KPMG) (2002–2006); Vice Chairman, Industrial Markets, KPMG (1998–2002). Trustee of various trusts within the John Hancock Fund Complex (since 2008). |

---

23 JOHN HANCOCK COLLATERAL TRUST \| ANNUAL REPORT

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;**Non-Independent Trustees<sup>3</sup>** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Name, year of birth<br> Position(s) held with Trust<br> Principal occupation(s) and other<br> directorships during past 5 years** | &nbsp;&nbsp;&nbsp;**Trustee<br> of the<br> Trust<br> since<sup>1</sup>** | &nbsp;&nbsp;&nbsp;**Number of John<br> Hancock funds<br> overseen by<br> Trustee** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Andrew G. Arnott, Born: 1971** | &nbsp;&nbsp;&nbsp;**2017** | &nbsp;&nbsp;&nbsp;**184** |
| &nbsp;&nbsp;&nbsp;*President and Non-Independent Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Global Head of Retail for Manulife (since 2022); Head of Wealth and Asset Management, United States and Europe, for John Hancock and Manulife (since 2018); Director and Executive Vice President, John Hancock Investment Management LLC (since 2005, including prior positions); Director and Executive Vice President, John Hancock Variable Trust Advisers LLC (since 2006, including prior positions); President, John Hancock Investment Management Distributors LLC (since 2004, including prior positions); President of various trusts within the John Hancock Fund Complex (since 2007, including prior positions). Trustee of various trusts within the John Hancock Fund Complex (since 2017). | &nbsp;&nbsp;&nbsp;Global Head of Retail for Manulife (since 2022); Head of Wealth and Asset Management, United States and Europe, for John Hancock and Manulife (since 2018); Director and Executive Vice President, John Hancock Investment Management LLC (since 2005, including prior positions); Director and Executive Vice President, John Hancock Variable Trust Advisers LLC (since 2006, including prior positions); President, John Hancock Investment Management Distributors LLC (since 2004, including prior positions); President of various trusts within the John Hancock Fund Complex (since 2007, including prior positions). Trustee of various trusts within the John Hancock Fund Complex (since 2017). | &nbsp;&nbsp;&nbsp;Global Head of Retail for Manulife (since 2022); Head of Wealth and Asset Management, United States and Europe, for John Hancock and Manulife (since 2018); Director and Executive Vice President, John Hancock Investment Management LLC (since 2005, including prior positions); Director and Executive Vice President, John Hancock Variable Trust Advisers LLC (since 2006, including prior positions); President, John Hancock Investment Management Distributors LLC (since 2004, including prior positions); President of various trusts within the John Hancock Fund Complex (since 2007, including prior positions). Trustee of various trusts within the John Hancock Fund Complex (since 2017). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Marianne Harrison, Born: 1963** | &nbsp;&nbsp;&nbsp;**2018** | &nbsp;&nbsp;&nbsp;**183** |
| &nbsp;&nbsp;&nbsp;*Non-Independent Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;President and CEO, John Hancock (since 2017); President and CEO, Manulife Canadian Division (2013–2017); Member, Board of Directors, Boston Medical Center (since 2021); Member, Board of Directors, CAE Inc. (since 2019); Member, Board of Directors, MA Competitive Partnership Board (since 2018); Member, Board of Directors, American Council of Life Insurers (ACLI) (since 2018); Member, Board of Directors, Communitech, an industry-led innovation center that fosters technology companies in Canada (2017-2019); Member, Board of Directors, Manulife Assurance Canada (2015-2017); Board Member, St. Mary's General Hospital Foundation (2014-2017); Member, Board of Directors, Manulife Bank of Canada (2013-2017); Member, Standing Committee of the Canadian Life & Health Assurance Association (2013-2017); Member, Board of Directors, John Hancock USA, John Hancock Life & Health, John Hancock New York (2012–2013 and since 2017). Trustee of various trusts within the John Hancock Fund Complex (since 2018). | &nbsp;&nbsp;&nbsp;President and CEO, John Hancock (since 2017); President and CEO, Manulife Canadian Division (2013–2017); Member, Board of Directors, Boston Medical Center (since 2021); Member, Board of Directors, CAE Inc. (since 2019); Member, Board of Directors, MA Competitive Partnership Board (since 2018); Member, Board of Directors, American Council of Life Insurers (ACLI) (since 2018); Member, Board of Directors, Communitech, an industry-led innovation center that fosters technology companies in Canada (2017-2019); Member, Board of Directors, Manulife Assurance Canada (2015-2017); Board Member, St. Mary's General Hospital Foundation (2014-2017); Member, Board of Directors, Manulife Bank of Canada (2013-2017); Member, Standing Committee of the Canadian Life & Health Assurance Association (2013-2017); Member, Board of Directors, John Hancock USA, John Hancock Life & Health, John Hancock New York (2012–2013 and since 2017). Trustee of various trusts within the John Hancock Fund Complex (since 2018). | &nbsp;&nbsp;&nbsp;President and CEO, John Hancock (since 2017); President and CEO, Manulife Canadian Division (2013–2017); Member, Board of Directors, Boston Medical Center (since 2021); Member, Board of Directors, CAE Inc. (since 2019); Member, Board of Directors, MA Competitive Partnership Board (since 2018); Member, Board of Directors, American Council of Life Insurers (ACLI) (since 2018); Member, Board of Directors, Communitech, an industry-led innovation center that fosters technology companies in Canada (2017-2019); Member, Board of Directors, Manulife Assurance Canada (2015-2017); Board Member, St. Mary's General Hospital Foundation (2014-2017); Member, Board of Directors, Manulife Bank of Canada (2013-2017); Member, Standing Committee of the Canadian Life & Health Assurance Association (2013-2017); Member, Board of Directors, John Hancock USA, John Hancock Life & Health, John Hancock New York (2012–2013 and since 2017). Trustee of various trusts within the John Hancock Fund Complex (since 2018). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Paul Lorentz,<sup>†</sup> Born: 1968** | &nbsp;&nbsp;&nbsp;**2022** | &nbsp;&nbsp;&nbsp;**183** |
| &nbsp;&nbsp;&nbsp;*Non-Independent Trustee* |  |  |
| &nbsp;&nbsp;&nbsp;Global Head, Manulife Wealth and Asset Management (since 2017); General Manager, Manulife, Individual Wealth Management and Insurance (2013–2017); President, Manulife Investments (2010–2016). Trustee of various trusts within the John Hancock Fund Complex (since 2022). | &nbsp;&nbsp;&nbsp;Global Head, Manulife Wealth and Asset Management (since 2017); General Manager, Manulife, Individual Wealth Management and Insurance (2013–2017); President, Manulife Investments (2010–2016). Trustee of various trusts within the John Hancock Fund Complex (since 2022). | &nbsp;&nbsp;&nbsp;Global Head, Manulife Wealth and Asset Management (since 2017); General Manager, Manulife, Individual Wealth Management and Insurance (2013–2017); President, Manulife Investments (2010–2016). Trustee of various trusts within the John Hancock Fund Complex (since 2022). |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;**Principal officers who are not Trustees** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Name, year of birth<br> Position(s) held with Trust<br> Principal occupation(s)<br> during past 5 years** | &nbsp;&nbsp;&nbsp;**Current<br> Position(s)<br> with the<br> Trust<br> since** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Charles A. Rizzo, Born: 1957** | &nbsp;&nbsp;&nbsp;**2015** |
| &nbsp;&nbsp;&nbsp;*Chief Financial Officer* |  |
| &nbsp;&nbsp;&nbsp;Vice President, John Hancock Financial Services (since 2008); Senior Vice President, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (since 2008); Chief Financial Officer of various trusts within the John Hancock Fund Complex (since 2007). | &nbsp;&nbsp;&nbsp;Vice President, John Hancock Financial Services (since 2008); Senior Vice President, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (since 2008); Chief Financial Officer of various trusts within the John Hancock Fund Complex (since 2007). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Salvatore Schiavone, Born: 1965** | &nbsp;&nbsp;&nbsp;**2015** |
| &nbsp;&nbsp;&nbsp;*Treasurer* |  |
| &nbsp;&nbsp;&nbsp;Assistant Vice President, John Hancock Financial Services (since 2007); Vice President, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (since 2007); Treasurer of various trusts within the John Hancock Fund Complex (since 2007, including prior positions). | &nbsp;&nbsp;&nbsp;Assistant Vice President, John Hancock Financial Services (since 2007); Vice President, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (since 2007); Treasurer of various trusts within the John Hancock Fund Complex (since 2007, including prior positions). |

---

ANNUAL REPORT \| JOHN HANCOCK COLLATERAL TRUST 24

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;**Principal officers who are not Trustees (continued)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Name, year of birth<br> Position(s) held with Trust<br> Principal occupation(s)<br> during past 5 years** | &nbsp;&nbsp;&nbsp;**Current<br> Position(s)<br> with the<br> Trust<br> since** |
| &nbsp;&nbsp;&nbsp;&nbsp;**Christopher (Kit) Sechler, Born: 1973** | &nbsp;&nbsp;&nbsp;**2018** |
| &nbsp;&nbsp;&nbsp;*Secretary and Chief Legal Officer* |  |
| &nbsp;&nbsp;&nbsp;Vice President and Deputy Chief Counsel, John Hancock Investment Management (since 2015); Assistant Vice President and Senior Counsel (2009–2015), John Hancock Investment Management; Assistant Secretary of John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (since 2009); Chief Legal Officer and Secretary of various trusts within the John Hancock Fund Complex (since 2009, including prior positions). | &nbsp;&nbsp;&nbsp;Vice President and Deputy Chief Counsel, John Hancock Investment Management (since 2015); Assistant Vice President and Senior Counsel (2009–2015), John Hancock Investment Management; Assistant Secretary of John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (since 2009); Chief Legal Officer and Secretary of various trusts within the John Hancock Fund Complex (since 2009, including prior positions). |
| &nbsp;&nbsp;&nbsp;&nbsp;**Trevor Swanberg, Born: 1979** | &nbsp;&nbsp;&nbsp;**2020** |
| &nbsp;&nbsp;&nbsp;*Chief Compliance Officer* |  |
| &nbsp;&nbsp;&nbsp;Chief Compliance Officer, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (since 2020); Deputy Chief Compliance Officer, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (2019–2020); Assistant Chief Compliance Officer, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (2016–2019); Vice President, State Street Global Advisors (2015–2016); Chief Compliance Officer of various trusts within the John Hancock Fund Complex (since 2016, including prior positions). | &nbsp;&nbsp;&nbsp;Chief Compliance Officer, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (since 2020); Deputy Chief Compliance Officer, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (2019–2020); Assistant Chief Compliance Officer, John Hancock Investment Management LLC and John Hancock Variable Trust Advisers LLC (2016–2019); Vice President, State Street Global Advisors (2015–2016); Chief Compliance Officer of various trusts within the John Hancock Fund Complex (since 2016, including prior positions). |

---

The business address for all Trustees and Officers is 200 Berkeley Street, Boston, Massachusetts 02116-5023.

The Statement of Additional Information of the fund includes additional information about members of the Board of Trustees of the Trust and is available without charge, upon request, by calling 800-225-5291.

---

| | |
|:---|:---|
| <sup>1</sup> | Each Trustee holds office until his or her successor is duly elected and qualified, or until the Trustee's death, retirement, resignation, or removal. Mr. Boyle has served as Trustee at various times prior to the date listed in the table. |
| <sup>2</sup> | Member of the Audit Committee. |
| <sup>3</sup> | The Trustee is a Non-Independent Trustee due to current or former positions with the Advisor and certain affiliates. |
| <sup>\*</sup> | Elected to serve as Independent Trustee effective as of September 9, 2022. |
| <sup>†</sup> | Elected to serve as Non-Independent Trustee effective as of September 9, 2022. |

---

25 JOHN HANCOCK COLLATERAL TRUST \| ANNUAL REPORT

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

More information

#### Trustees
Hassell H. McClellan, *Chairperson* Steven R. Pruchansky, *Vice Chairperson* Andrew G. Arnott<sup>†</sup>

James R. Boyle

William H. Cunningham<sup>\*</sup>

Noni L. Ellison

<sup>^</sup>Grace K. Fey

Dean C. Garfield<sup>^</sup>

Marianne Harrison<sup>†</sup>

Deborah C. Jackson

Patricia Lizarraga<sup>\*,^</sup>

Paul Lorentz<sup>‡</sup>

Frances G. Rathke<sup>\*</sup>

Gregory A. Russo

#### Officers
Andrew G. Arnott

*President*

Charles A. Rizzo

*Chief Financial Officer*

Salvatore Schiavone

*Treasurer*

Christopher (Kit) Sechler

*Secretary and Chief Legal Officer*

Trevor Swanberg

*Chief Compliance Officer*

#### Investment advisor
John Hancock Investment Management LLC

#### Subadvisor
Manulife Investment Management (US) LLC

#### Portfolio Managers
Bridget Bruce

Christopher Coccoluto

Michael Lorizio

James Madison

Connor Minnaar, CFA<sup>1</sup>

#### Placement Agent
John Hancock Investment Management Distributors LLC

#### Custodian
State Street Bank and Trust Company

#### Transfer agent
John Hancock Signature Services, Inc.

#### Legal counsel
K&L Gates LLP

#### Independent registered public accounting firm
PricewaterhouseCoopers LLP

<sup>†</sup> Non-Independent Trustee

\* Member of the Audit Committee

^ Elected to serve as Independent Trustee effective as of September 9, 2022.

‡ Elected to serve as Non-Independent Trustee effective as of September 9, 2022.

<sup>1</sup> Effective March 31, 2022, Connor Minnaar, CFA was added as a portfolio manager of the fund.

The fund's proxy voting policies and procedures, as well as the fund proxy voting record for the most recent twelve-month period ended June 30, are available free of charge on the Securities and Exchange Commission (SEC) website at sec.gov.

The fund files with the SEC a complete schedule of its portfolio holdings as of the close of each month on Form N-MFP. Form N-MFP is available on the SEC's website at sec.gov. Shareholders may access Form N-MFP via the link to the fund at https://www.jhinvestments.com/collateral-trust.

We make this information on your fund available by calling 800-225-5291.

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;You can also contact us: |  |  |
| &nbsp;&nbsp;**800-225-5291** | &nbsp;&nbsp;**Regular mail:** | &nbsp;&nbsp;**Express mail:** |
| &nbsp;&nbsp;**jhinvestments.com** | &nbsp;&nbsp;John Hancock Signature Services, Inc.<br> P.O. Box 219909<br> Kansas City, MO 64121-9909 | &nbsp;&nbsp;John Hancock Signature Services, Inc.<br> 430 W 7<sup>th</sup> Street<br> Suite 219909<br> Kansas City, MO 64105-1407 |

---

ANNUAL REPORT \| JOHN HANCOCK COLLATERAL TRUST 26

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

John Hancock family of funds

#### U.S. EQUITY FUNDS

------

Blue Chip Growth

Classic Value

Disciplined Value

Disciplined Value Mid Cap

Equity Income

Financial Industries

Fundamental All Cap Core

Fundamental Large Cap Core

Mid Cap Growth

New Opportunities

Regional Bank

Small Cap Core

Small Cap Growth

Small Cap Value

U.S. Global Leaders Growth

U.S. Growth

#### INTERNATIONAL EQUITY FUNDS

------

Disciplined Value International

Emerging Markets

Emerging Markets Equity

Fundamental Global Franchise

Global Environmental Opportunities

Global Equity

Global Shareholder Yield

Global Thematic Opportunities

International Dynamic Growth

International Growth

International Small Company

#### FIXED-INCOME FUNDS

------

Bond

California Municipal Bond

Emerging Markets Debt

Floating Rate Income

Government Income

High Yield

High Yield Municipal Bond

Income

Investment Grade Bond

Money Market

Municipal Opportunities

Opportunistic Fixed Income

Short Duration Bond

Short Duration Municipal Opportunities

Strategic Income Opportunities

#### ALTERNATIVE FUNDS

------

Alternative Asset Allocation

Diversified Macro

Infrastructure

Multi-Asset Absolute Return

Real Estate Securities

Seaport Long/Short

A fund's investment objectives, risks, charges, and expenses should be considered carefully before investing. The prospectus contains this and other important information about the fund. To obtain a prospectus, contact your financial professional, call John Hancock Investment Management at 800-225-5291, or visit our website at jhinvestments.com. Please read the prospectus carefully before investing or sending money.

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

#### EXCHANGE-TRADED FUNDS

------

John Hancock Corporate Bond ETF

John Hancock International High Dividend ETF

John Hancock Mortgage-Backed Securities ETF

John Hancock Multifactor Developed International ETF

John Hancock Multifactor Emerging Markets ETF

John Hancock Multifactor Large Cap ETF

John Hancock Multifactor Mid Cap ETF

John Hancock Multifactor Small Cap ETF

John Hancock Preferred Income ETF

John Hancock U.S. High Dividend ETF

#### ENVIRONMENTAL,SOCIAL, AND GOVERNANCE FUNDS

------

ESG Core Bond

ESG International Equity

ESG Large Cap Core

#### ASSET ALLOCATION/TARGET DATE FUNDS

------

Balanced

Multi-Asset High Income

Multi-Index Lifetime Portfolios

Multi-Index Preservation Portfolios

Multimanager Lifestyle Portfolios

Multimanager Lifetime Portfolios

#### CLOSED-END FUNDS

------

Asset-Based Lending

Financial Opportunities

Hedged Equity & Income

Income Securities Trust

Investors Trust

Preferred Income

Preferred Income II

Preferred Income III

Premium Dividend

Tax-Advantaged Dividend Income

Tax-Advantaged Global Shareholder Yield

*John Hancock ETF shares are bought and sold at market price (not NAV), and are not individually redeemed from the fund. Brokerage commissions will reduce returns.*

*John Hancock ETFs are distributed by Foreside Fund Services, LLC, and are subadvised by Manulife Investment Management (US) LLC or Dimensional Fund Advisors LP. Foreside is not affiliated with John Hancock Investment Management Distributors LLC, Manulife Investment Management (US) LLC or Dimensional Fund Advisors LP.*

*Dimensional Fund Advisors LP receives compensation from John Hancock in connection with licensing rights to the John Hancock Dimensional indexes. Dimensional Fund Advisors LP does not sponsor, endorse, or sell, and makes no representation as to the advisability of investing in, John Hancock Multifactor ETFs.*

------

[**Table of Contents**](#JOB_Colla_d56b180c-40f6-4917-bc70-ed5fbff1aee8_TofC)

A *trusted* brand

John Hancock Investment Management is a premier asset manager

with a heritage of financial stewardship dating back to 1862. Helping

our shareholders pursue their financial goals is at the core of everything

we do. It's why we support the role of professional financial advice

and operate with the highest standards of conduct and integrity.

A *better way* to invest

We serve investors globally through a unique multimanager approach:

We search the world to find proven portfolio teams with specialized

expertise for every strategy we offer, then we apply robust investment

oversight to ensure they continue to meet our uncompromising

standards and serve the best interests of our shareholders.

*Results for investors*

Our unique approach to asset management enables us to provide

a diverse set of investments backed by some of the world's best

managers, along with strong risk-adjusted returns across asset classes.

"A trusted brand" is based on a survey of 6,651 respondents conducted by Medallia between 3/18/20 and 5/13/20.

![](img6e597bbb2.gif)

John Hancock Investment Management Distributors LLC, Member FINRA, SIPC

200 Berkeley Street, Boston, MA 02116-5010, 800-225-5291, jhinvestments.com

Manulife Investment Management, the Stylized M Design, and Manulife Investment Management & Stylized M Design are trademarks of The Manufacturers Life Insurance Company and are used by its affiliates under license.

NOT FDIC INSURED. MAY LOSE VALUE. NO BANK GUARANTEE. NOT INSURED BY ANY GOVERNMENT AGENCY.

This report is for the information of the shareholders of John Hancock Collateral Trust. It is not authorized for distribution to prospective investors unless preceded or accompanied by a registration statement.

![](imgabce865d3.gif)

315A 12/22

2/2023

------

ITEM 2. CODE OF ETHICS.

As of the end of the year, December 31, 2022, the registrant has adopted a code of ethics, as defined in Item 2 of Form N-CSR, that applies to its Chief Executive Officer, Chief Financial Officer and Treasurer (respectively, the principal executive officer, the principal financial officer and the principal accounting officer, the "Covered Officers"). A copy of the code of ethics is filed as an exhibit to this Form N-CSR.

ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.

Frances G. Rathke is the audit committee financial expert, effective March 25, 2022, and is "independent", pursuant to general instructions on Form N-CSR Item 3.

ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

(a) Audit Fees

The aggregate fees billed for professional services rendered by the principal accountant(s) for the audit of the registrant's annual financial statements or services that are normally provided by the accountant(s) in connection with statutory and regulatory filings or engagements amounted to $38,909 for the fiscal year ended December 31, 2022 and $36,884 for the fiscal year ended December 31, 2021. These fees were billed to the registrant and were approved by the registrant's audit committee.

(b) Audit-Related Services

Audit-related service fees amounted to $586 for the fiscal year ended December 31, 2022 and $776 for the fiscal year ended December 31, 2021. These fees were billed to the registrant or to the registrant's investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the adviser that provides ongoing services to the registrant ("control affiliates"). The nature of the services provided was related to a software licensing fee and internal controls reviews. In addition, amounts billed to control affiliates for service provider internal controls reviews were $121,890 for the fiscal year ended December 31, 2022 and $119,500 for the fiscal year ended December 31, 2021.

(c) Tax Fees

The aggregate fees billed for professional services rendered by the principal accountant(s) for the tax compliance, tax advice and tax planning ("tax fees") amounted to $3,061 for the fiscal year ended December 31, 2022 and $2,915 for the fiscal year ended December 31, 2021. The nature of the services comprising the tax fees was the review of the registrant's tax returns and tax distribution requirements. These fees were billed to the registrant and were approved by the registrant's audit committee.

(d) All Other Fees

Other fees billed to the registrant or to the control affiliates amounted to $163 for the fiscal year ended December 31, 2022 and $289 for the fiscal year ended December 31, 2021. The nature of the services comprising all other fees is advisory services provided to the investment manager.

(e)(1) Audit Committee Pre-Approval Policies and Procedures:

The trust's Audit Committee must pre-approve all audit and non-audit services provided by the independent registered public accounting firm (the "Auditor") relating to the operations or financial reporting of the funds. Prior to the commencement of any audit or non-audit services to a fund, the Audit Committee reviews the services to determine whether they are appropriate and permissible under applicable law.

The Trust's Audit Committee has adopted policies and procedures to, among other purposes, provide a framework for the Committee's consideration of audit-related and non-audit services by

the Auditor. The policies and procedures require that any audit-related and non-audit service provided by the Auditor and any non-audit service provided by the Auditor to a fund service provider that relates directly to the operations and financial reporting of a fund are subject to approval by the Audit Committee before such service is provided. Audit-related services provided by the Auditor that are expected to exceed $25,000 per instance/per fund are subject to specific pre-approval by the Audit Committee. Tax services provided by the Auditor that are expected to exceed $30,000 per instance/per fund are subject to specific pre-approval by the Audit Committee.

All audit services, as well as the audit-related and non-audit services that are expected to exceed the amounts stated above, must be approved in advance of provision of the service by formal resolution of the Audit Committee. At the regularly scheduled Audit Committee meetings, the Committee reviews a report summarizing the services, including fees, provided by the Auditor.

(e)(2) Services approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X:

Audit-Related Fees, Tax Fees and All Other Fees:

There were no amounts that were approved by the Audit Committee pursuant to the de minimis exception under Rule 2-01 of Regulation S-X.

(f)According to the registrant's principal accountant, for the fiscal year ended December 31, 2022, the percentage of hours spent on the audit of the registrant's financial statements for the most recent fiscal year that were attributed to work performed by persons who were not full-time, permanent employees of principal accountant was less than 50%.

(g)The aggregate non-audit fees billed by the registrant's accountant(s) for services rendered to the registrant and rendered to the registrant's control affiliates of the registrant was $1,145,066 for the fiscal year ended December 31, 2022 and $988,448 for the fiscal year ended December 31, 2021.

(h)The audit committee of the registrant has considered the non-audit services provided by the registrant's principal accountant(s) to the control affiliates and has determined that the services that were not pre-approved are compatible with maintaining the principal accountant(s)' independence.

ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.

The registrant has a separately-designated standing audit committee comprised of independent trustees. The members of the audit committee are as follows:

Frances G. Rathke – Chairperson, effective March 25, 2022

Peter S. Burgess – retired December 31, 2022

William H. Cunningham

Patricia Lizarraga, effective September 20, 2022

ITEM 6. SCHEDULE OF INVESTMENTS.

(a)Not applicable.

(b)Not applicable.

ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED- END MANAGEMENT INVESTMENT COMPANIES.

Not applicable.

ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.

Not applicable.

ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.

Not applicable.

ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

There were no material changes to previously disclosed John Hancock Funds – Nominating and Governance Committee Charter. A copy of the procedures is filed as an exhibit to this Form N- CSR. See attached "John Hancock Funds -Nominating and Governance Committee Charter."

.

ITEM 11. CONTROLS AND PROCEDURES.

(a)Based upon their evaluation of the registrant's disclosure controls and procedures as conducted within 90 days of the filing date of this Form N-CSR, the registrant's principal executive officer and principal financial officer have concluded that those disclosure controls and procedures provide reasonable assurance that the material information required to be disclosed by the registrant on this report is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms.

(b)There were no changes in the registrant's internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant's internal control over financial reporting.

ITEM 12. DISCLOSURE OF SECURITIES LENDING ACTIVITIES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.

Not applicable.

ITEM 13. EXHIBITS.

[(a)(1) See attached Code of Ethics.](f12662d2.htm)

[(a)(2) Separate certifications for the registrant's principal executive officer and principal financial officer, as required by Section 302 of the Sarbanes-Oxley Act of 2002 and Rule 30a-2(a) under the Investment Company Act of 1940, are attached.](f12662d3.htm)

[(b)Separate certifications for the registrant's principal executive officer and principal financial officer, as required by 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and Rule 30a-2(b) under the Investment Company Act of 1940, are attached. The certifications furnished pursuant to this paragraph are not deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. Such certifications are not deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that the Registrant specifically incorporates them by reference.](f12662d4.htm)

[(c)(1) Submission of Matters to a Vote of Security Holders is attached. See attached "John Hancock Funds – Governance Committee Charter".](f12662d5.htm)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

John Hancock Collateral Trust

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp; /s/ Andrew Arnott |
|  | &nbsp;&nbsp; ------------------------------ |
|  | &nbsp;&nbsp; Andrew Arnott |
|  | &nbsp;&nbsp; President |
| Date: | February 21, 2023 |

---

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | |
|:---|:---|
| By: | &nbsp;&nbsp; /s/ Andrew Arnott |
|  | &nbsp;&nbsp; ------------------------------- |
|  | &nbsp;&nbsp; Andrew Arnott |
|  | &nbsp;&nbsp; President |
| Date: | February 21, 2023 |
| By: | &nbsp;&nbsp; /s/ Charles A. Rizzo |
|  | &nbsp;&nbsp; ------------------------------- |
|  | &nbsp;&nbsp; Charles A. Rizzo |
|  | &nbsp;&nbsp; Chief Financial Officer |
| Date: | &nbsp;&nbsp; February 21, 2023 |

---

------

## Ex-99.(A)(1)

![](gsu3wq74mbstvb77yosab.jpg)

**JOHN HANCOCK VARIABLE INSURANCE TRUST**

**JOHN HANCOCK FUNDS**

**JOHN HANCOCK FUNDS II**

**JOHN HANCOCK EXCHANGE-TRADED FUND TRUST**

**<u><u>S</u>ARBANES<u>-O</u>XLEY <u>C</u>ODE OF <u>E</u>THICS</u>**

**<u>FOR</u>**

**<u><u>P</u>RINCIPAL <u>E</u>XECUTIVE<u>, P</u>RINCIPAL <u>F</u>INANCIAL <u>O</u>FFICER <u>& T</u>REASURER</u>**

**I.Covered Officers/Purpose of the Code**

This code of ethics (this "Code") for John Hancock Variable Insurance Trust, John Hancock Funds[<sup>1</sup>](#page_1), and John Hancock Funds II, John Hancock Exchange-Traded Fund Trust and, each a registered management investment company under the Investment Company Act of 1940, as amended ("1940 Act"), which may issue shares in separate and distinct series (each investment company and series thereunder to be hereinafter referred to as a "Fund"), applies to each Fund's Principal Executive Officer ("President"), Principal Financial Officer ("Chief Financial Officer") and Treasurer ("Treasurer") (the "Covered Officers" as set forth in <u>Exhibit A</u>) for the purpose of promoting:

****honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

****full, fair, accurate, timely and understandable disclosure in reports and documents that the Fund files with, or submits to, the Securities and Exchange Commission ("SEC") and in other public communications made by the Fund;

****compliance with applicable laws and governmental rules and regulations;

****the prompt internal reporting of violations of the Code to an appropriate person or persons identified in the Code; and

****accountability for adherence to the Code.

1John Hancock Funds includes the following trusts: John Hancock Financial Opportunities Fund; John Hancock Bond Trust; John Hancock California Tax-Free Income Fund; John Hancock Capital Series; John Hancock Funds III; John

Hancock Income Securities Trust; John Hancock Investment Trust; John Hancock Investment Trust II; John Hancock Investors Trust; John Hancock Municipal Securities Trust; John Hancock Premium Dividend Fund ; John Hancock Preferred Income Fund; John Hancock Preferred Income Fund II; John Hancock Preferred Income Fund III; John Hancock Sovereign Bond Fund; John Hancock Strategic Series; John Hancock Tax-Advantaged Dividend Income Fund; John Hancock Tax-Advantaged Global Shareholder Yield Fund; John Hancock Hedged Equity and Income Fund; and John Hancock Collateral Trust.

1 of 6

Each of the Covered Officers should adhere to a high standard of business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.

**II.Covered Officers Should Handle Ethically Actual and Apparent Conflicts of Interest Overview**

A "conflict of interest" occurs when a Covered Officer's private interest interferes with the interests of, or his service to, the Fund. For example, a conflict of interest would arise if a Covered Officer, or a member of his family, receives improper personal benefits as a result of his position with the Fund. Certain conflicts of interest arise out of the relationships between the Covered Officers and the Fund and already are subject to conflict of interest provisions in the Investment Company Act of 1940, as amended (the "Investment Company Act") and the Investment Advisers Act of 1940, as amended (the "Investment Advisers Act"). For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with the Fund because of their status as "affiliated persons" of the Fund. Each of the Covered Officers is an officer or employee of the investment adviser or a service provider ("Service Provider") to the Fund. The Fund's, the investment adviser's and the Service Provider's compliance programs and procedures are designed to prevent, or identify and correct, violations of these provisions. This Code does not, and is not intended to, repeat or replace these programs and procedures, and such conflicts fall outside of the parameters of this Code.

Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between the Fund and the investment adviser and the Service Provider of which the Covered Officers are also officers or employees. As a result, this Code recognizes that the Covered Officers will, in the normal course of their duties (whether formally for the Fund, for the investment adviser or for the Service Provider), be involved in establishing policies and implementing decisions which will have different effects on the investment adviser, the Service Provider and the Fund. The participation of the Covered Officers in such activities is inherent in the contractual relationship between the Fund and the investment adviser and the Service Provider and is consistent with the performance by the Covered Officers of their duties as officers of the Fund. Thus, if such participation is performed in conformity with the provisions of the Investment Company Act and the Investment Advisers Act, it will be deemed to have been handled ethically. In addition, it is recognized by the Fund's Board of Trustees/Directors (the "Board") that the Covered Officers may also be officers or employees of one or more other investment companies covered by other Codes.

Other conflicts of interest are covered by the Code, even if such conflicts of interest are not subject to provisions in the Investment Company Act and the Investment Advisers Act. The following list provides examples of conflicts of interest under the Code, but the Covered Officers should keep in mind that these examples are not exhaustive. The overarching principle is that the personal interest of a Covered Officer should not be placed improperly before the interest of the Fund.

\*\*\*

2 of 6

Each Covered Officer must:

****not use his/her personal influence or personal relationships improperly to influence investment decisions or financial reporting by the Fund whereby the Covered Officer would benefit personally to the detriment of the Fund;

****not cause the Fund to take action, or fail to take action, for the individual personal benefit of the Covered Officer rather than for the benefit of the Fund; and

****not use material non-public knowledge of portfolio transactions made or contemplated for the Fund to trade personally or cause others to trade personally in contemplation of the market effect of such transactions.

Additionally, conflicts of interest may arise in other situations, the propriety of which may be discussed, if material, with the Fund's Chief Compliance Officer ("CCO"). Examples of these include:

****serve as a director/trustee on the board of any public or private company;

****the receipt of any non-nominal gifts;

****the receipt of any entertainment from any company with which the Fund has current or prospective business dealings unless such entertainment is business-related, reasonable in cost, appropriate as to time and place, and not so frequent as to raise any question of impropriety (or other formulation as the Fund already uses in another code of conduct);

****any ownership interest in, or any consulting or employment relationship with, any of the Fund's service providers, other than its investment adviser, any sub-adviser, principal underwriter, administrator or any affiliated person thereof; and

****a direct or indirect financial interest in commissions, transaction charges or spreads paid by the Fund for effecting portfolio transactions or for selling or redeeming shares other than an interest arising from the Covered Officer's employment, such as compensation or equity ownership.

**III.Disclosure & Compliance**

****Each Covered Officer should familiarize himself or herself with the disclosure requirements generally applicable to the Fund;

****Each Covered Officer should not knowingly misrepresent, or cause others to misrepresent, facts about the Fund to others, whether within or outside the Fund, including to the Fund's directors and auditors, and to governmental regulators and self- regulatory organizations;

3 of 6

****Each Covered Officer should, to the extent appropriate within his/her area of responsibility, consult with other officers and employees of the Fund and the Fund's adviser or any sub-adviser with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Fund files with, or submits to, the SEC and in other public communications made by the Fund; and

****It is the responsibility of each Covered Officer to promote compliance with the standards and restrictions imposed by applicable laws, rules and regulations.

IV. Reporting & Accountability

Each Covered Officer must:

****upon adoption of the Code (or thereafter as applicable, upon becoming an Covered Officer), affirm in writing to the Fund's CCO that he/she has received, read, and understands the Code;

****annually thereafter affirm to the Fund's CCO that he/she has complied with the requirements of the Code;

****not retaliate against any employee or Covered Officer or their affiliated persons for reports of potential violations that are made in good faith;

****notify the Fund's CCO promptly if he/she knows of any violation of this Code (Note: failure to do so is itself a violation of this Code); and

****report at least annually any change in his/her affiliations from the prior year.

The Fund's CCO is responsible for applying this Code to specific situations in which questions are presented under it and has the authority to interpret this Code in any particular situation. However, any approvals or waivers sought by the Principal Executive Officer will be considered by the Fund's Board or the Compliance Committee thereof (the "Committee").

The Fund will follow these procedures in investigating and enforcing this Code:

****the Fund's CCO will take all appropriate action to investigate any potential violations reported to him/her;

****if, after such investigation, the CCO believes that no violation has occurred, the CCO is not required to take any further action;

****any matter that the CCO believes is a violation will be reported to the Board or, if applicable, Compliance Committee;

****if the Board or, if applicable, Compliance Committee concurs that a violation has occurred, the Board, either upon its determination of a violation or upon

4 of 6

recommendation of the Compliance Committee, if applicable, will consider appropriate action, which may include review of, and appropriate modifications to, applicable policies and procedures; notification to appropriate personnel of the Service Provider or the investment adviser or its board; or a recommendation to dismiss the Registrant's Executive Officer;

****the Board, or if applicable the Compliance Committee, will be responsible for granting waivers, as appropriate; and

****any changes to or waivers of this Code will, to the extent required, be disclosed as provided by SEC rules.

**V.Other Policies & Procedures**

This Code shall be the sole code of ethics adopted by the Fund for purposes of Section 406 of the Sarbanes-Oxley Act of 2002 and the rules and forms applicable to registered investment companies thereunder. Insofar as other policies or procedures of the Fund, the Fund's adviser, any sub- adviser, principal underwriter or other service providers govern or purport to govern the behavior or activities of the Covered Officers who are subject to this Code, they are superseded by this Code to the extent that they overlap or conflict with the provisions of this Code. The Fund's and its investment adviser's codes of ethics under Rule 204A-1 under the Investment Advisers Act and Rule 17j-1 under the Investment Company Act, respectively, are separate requirements applying to the Covered Officers and others and are not part of this Code.

VI. Amendments

Any amendments to this Code, other than amendments to Exhibit A, must be approved or ratified by a majority vote of the Fund's Board, including a majority of independent directors.

VII. Confidentiality

All reports and records prepared or maintained pursuant to this Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or this Code, such matters shall not be disclosed to anyone other than the Fund's Board and its counsel, the investment adviser and the relevant Service Providers.

VIII. Internal Use

The Code is intended solely for the internal use by the Fund and does not constitute an admission, by or on behalf of the Fund, as to any fact, circumstance, or legal conclusion.

5 of 6

**<u>Exhibit A</u>**

**Persons Covered by this Code of Ethics**

**(As of December 31, 2022)**

**John Hancock Variable Insurance Trust**

****Principal Executive Officer and President – Andrew Arnott

****Principal Financial Officer and Chief Financial Officer – Charles Rizzo

****Treasurer – Salvatore Schiavone

**John Hancock Funds**

****Principal Executive Officer and President – Andrew Arnott

****Principal Financial Officer and Chief Financial Officer – Charles Rizzo

****Treasurer – Salvatore Schiavone

**John Hancock Funds II**

****Principal Executive Officer and President – Andrew Arnott

****Principal Financial Officer and Chief Financial Officer – Charles Rizzo

****Treasurer – Salvatore Schiavone

**John Hancock Exchange-Traded Trust**

****Principal Executive Officer and President – Andrew Arnott

****Principal Financial Officer and Chief Financial Officer – Charles Rizzo

****Treasurer – Salvatore Schiavone

6 of 6

## Ex-99.(A)(2)

**<u>CERTIFICATION</u>**

I, Andrew Arnott, certify that:

1. I have reviewed this report on Form N-CSR of the John Hancock Collateral Trust (the "registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during period covered by this report has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: <u>February 21, 2023</u> | <u>/s/ Andrew Arnott</u> |
|  | Andrew Arnott |
|  | President |

---

------

**<u>CERTIFICATION</u>**

I, Charles A. Rizzo, certify that:

1. I have reviewed this report on Form N-CSR of the John Hancock Collateral Trust (the "registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during period covered by this report has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: <u>February 21, 2023</u> | <u>/s/ Charles A. Rizzo</u> |
|  | Charles A. Rizzo |
|  | Chief Financial Officer |

---

------

## Ex-99.(B)

![](gneuxb78n3eeorfihzmwm.jpg)

**Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of**

**the Sarbanes-Oxley Act of 2002\***

In connection with the attached Report of John Hancock Collateral Trust (the "registrant") on Form N-CSR to be filed with the Securities and Exchange Commission (the "Report"), each of the undersigned officers of the registrant does hereby certify that, to the best of such officer's knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant as of, and for, the periods presented in the Report.

<u>/s/ Andrew Arnott</u> Andrew Arnott President

Dated: February 21, 2023

<u>/s/ Charles A. Rizzo</u> Charles A. Rizzo

Chief Financial Officer

Dated: February 21, 2023

A signed original of this written statement, required by Section 906, has been provided to the registrant and will be retained by the registrant and furnished to the Securities and Exchange Commission or its staff upon request.

\*These certifications are being furnished solely pursuant to 18 U.S.C. Section 1350 and are not being filed as part of this Form N-CSR or as a separate disclosure document.

## Ex-99.(C)(1)

![](gn9oh5zpd4tt7suq2lyzj.jpg)

**JOHN HANCOCK FUNDS[<sup>1</sup>](#page_1)**

**<u>NOMINATING AND GOVERNANCE COMMITTEE CHARTER</u>**

**Overall Role and Responsibility**

The Nominating and Governance Committee (the "Committee") of each of the Trusts shall (1) make determinations and recommendations to the Board of Trustees (the "Board") regarding issues related to (a) the composition of the Board and (b) corporate governance matters applicable to the Trustees who are not "interested persons" as defined in the Investment Company Act of 1940, as amended (the "1940 Act"), of any of the Trusts, or of any Fund's investment adviser, subadviser or principal underwriter and who are "independent" as defined in the rules of the New York Stock Exchange ("NYSE") (the "Independent Trustees") and (2) discharge such additional duties, responsibilities and functions as are delegated to it from time to time.

**Membership**

The Nominating and Governance Committee (the "Committee") shall be composed of all of the Independent Trustees of the Board. One member of the Committee shall be appointed by the Board as Chair of the Committee. The chair shall be responsible for leadership of the Committee, including scheduling meetings or reviewing and approving the schedule for them, preparing agendas or reviewing and approving them before meetings, presiding over meetings of the Committee and making reports to the full Board, as appropriate.

**Structure, Operations and Governance**

<u>Meetings and Actions by Written Consent</u>. The Committee shall meet as often as required or as the Committee deems appropriate, with or without management present. Meetings may be called and notice given by the Committee chair or a majority of the members of the Committee. Members may attend meetings in person or by telephone. The Committee may act by written consent to the extent permitted by law and the Funds' governing documents. The Committee shall report to the Board on any significant action it takes not later than the next following Board meeting.

<u>Required Vote and Quorum</u>. The affirmative vote of a majority of the members of the Committee participating in any meeting of the Committee at which a quorum is present is necessary for the adoption of any resolution. At least a majority of the Committee members present at the meeting in person or by telephone shall constitute a quorum for the transaction of business.

1"John Hancock Funds" includes each trust and series as may be amended from time to time (each individually, a "Trust," and collectively, the "Trusts," and each series thereof, a "Portfolio" or "Fund," and collectively, the "Portfolios" or "Funds").

<u>Delegation to Subcommittees</u>. The Committee may delegate any portion of its authority to a subcommittee of one or more members.

<u>Appropriate Resources and Authority</u>. The Committee shall have the resources and authority appropriate to discharge its responsibilities, including the authority to retain special counsel and other advisers, experts or consultants, at the Funds' expense, as it determines necessary or appropriate to carry out its duties and responsibilities. In addition, the Committee shall have direct access to such officers of and service providers to the Funds as it deems desirable.

<u>Review of Charter</u>. The Committee Charter shall be approved by at least a majority of the Independent Trustees of the Trust. The Committee shall review and assess the adequacy of this Charter periodically and, where necessary or as it deems desirable, will recommend changes to the Board for its approval. The Board may amend this Charter at any time in response to recommendations from the Committee or on its own motion.

<u>Executive Sessions</u>. The Committee may meet privately and may invite non-members to attend such meetings. The Committee may meet with representatives of the Investment Management Services department of the Funds' advisers, internal legal counsel of the Funds' advisers, members of the John Hancock Funds Risk & Investment Operations Committee (the "RIO Committee") and with representatives of the Funds' service providers, including the subadvisers, to discuss matters that relate to the areas for which the Committee has responsibility.

**Specific Duties and Responsibilities**

The Committee shall have the following duties and powers, to be exercised at such times and in such manner as the Committee shall determine:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Except where a Trust is legally required to nominate individuals recommended by another, to identify individuals qualified to serve as Independent Trustees of the Trusts, and to consider and recommend to the full Board nominations of individuals to serve as Trustees.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.To consider, as it deems necessary or appropriate, the criteria for persons to fill existing or newly created Trustee vacancies. The Committee shall use the criteria and principles set forth in Annex A to guide its Trustee selection process.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.To consider and recommend changes to the Board regarding the size, structure, and composition of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.To evaluate, from time to time, and determine changes to the retirement policies for the Independent Trustees, as appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.To periodically review the Board's committee structure and, in collaboration with the Chairs of the various Committees, the charters of the Board's committees, and

recommend to the Board of Trustees changes to the committee structure and charters as it deems appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.To retain and terminate any firm(s) to be used to identify or evaluate or assist in identifying or evaluating potential Independent Board nominees, subject to the Board's sole authority to approve the firm's fees and other retention terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.To consider and determine the amount of compensation to be paid by the Trusts to the Independent Trustees, including the compensation of the Chair of the Board or any Vice-Chair of the Board and of Committee Chairs, and to address compensation-related matters. The Chair of the Board has been granted the authority to approve special compensation to Independent Trustees in recognition of any significant amount of additional time and service to the Trusts provided by them, subject to ratification of any such special compensation by the Committee at the next regular meeting of the Committee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.To coordinate and administer an annual self-evaluation of the Board, which will include, at a minimum, a review of its effectiveness in overseeing the number of Funds in the Fund complex and the effectiveness of its committee structure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.To review the Board Governance Procedures and recommend to the Board of Trustees changes to the Procedures as the Committee deems appropriate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.To report its activities to the full Board and to make such recommendations with respect to the matters described above and other matters as the Committee may deem necessary or appropriate.

**Additional Responsibilities**

The Committee will also perform other tasks assigned to it from time to time by the Chair of the Board or by the Board, and will report findings and recommendations to the Board, as appropriate.

Last revised: December 12, 2018

<u>ANNEX A</u>

The Committee may take into account a wide variety of factors in considering Trustee candidates, including (but not limited to) the criteria set forth below. The Committee may determine that a candidate who does not satisfy these criteria in one or more respects should nevertheless be considered as a nominee if the Committee finds that the criteria satisfied by the candidate and the candidate's other qualifications demonstrate the appropriate level of fitness to serve.

**General Criteria**

1. Nominees should have a reputation for integrity, honesty and adherence to high ethical standards, and such other personal characteristics as a capacity for leadership and the ability to work well with others.

2. Nominees should have business, professional, academic, financial, accounting or other experience and qualifications which demonstrate that they will make a valuable contribution as Trustees.

3. Nominees should have a commitment to understand the Funds, and the responsibilities of a trustee/director of an investment company and to regularly attend and participate in meetings of the Board and its committees.

4. Nominees should have the ability to understand the sometimes conflicting interests of the various constituencies of the Funds, including shareholders and the investment adviser, and to act in the interests of all shareholders.

5. Nominees should not have, nor appear to have, a conflict of interest that would impair their ability to represent the interests of all the shareholders and to fulfill the responsibilities of a trustee.

6. Nominees should have experience on corporate or other institutional bodies having oversight responsibilities.

It is the intent of the Committee that at least one Independent Trustee be an "audit committee financial expert" as that term is defined in Item 3 of Form N-CSR.

Application of Criteria to Current Trustees

The re-nomination of current Trustees should not be viewed as automatic, but should be based on continuing qualification under the criteria set forth above based on, among other things, the current Trustee's contribution to the Board and any committee on which he or she serves.

**Review of Nominations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Committee believes that it is in the best interests of each Trust and its shareholders to obtain highly-qualified candidates to serve as members of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.In nominating candidates who would be Independent Trustees, the Committee believes that no particular qualities or skills nor any specific minimum qualifications or disqualifications are controlling or paramount. The Committee shall take into consideration any such factors as it deems appropriate; however, the appropriate mix of skills, expertise and attributes needed to maintain an effective board are sought in the applicant pool as part of every search the Board undertakes for new trustees, including but not limited to the diversity of thought, as well as of gender, race, ethnic background and geographic origin. These factors may also include (but are not limited to) the person's character, integrity, judgment, skill and experience with investment companies and other organizations of comparable purpose, complexity and size and subject to similar legal restrictions and oversight; the interplay of the candidate's experience with the experience of other Board members; and the extent to which the candidate would be a desirable addition to the Board and any Committees thereof. Other factors that the Committee may take into consideration include a person's availability and commitment to attend meetings and perform his or her responsibilities; whether or not the person has or had any relationships that might impair or appear to impair his or her independence, such as any business, financial or family relationships with Fund management, the investment adviser and/or any subadviser of the Funds, as applicable, Fund service providers, or their affiliates or with Fund shareholders. The Committee will strive to achieve a group that reflects a diversity of experiences in respect of industries, professions and other experiences, and that is diversified as to thought, gender, race, ethnic background and geographic origin.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.While the Committee is solely responsible for the selection and recommendation to the Board of Independent Trustee candidates, the Committee may consider nominees recommended by any source, including shareholders, management, legal counsel and Board members, as it deems appropriate. The Committee may retain a professional search firm or a consultant to assist the Committee in a search for a qualified candidate. Any recommendations from shareholders shall be directed to the Secretary of the relevant Trust at such address as is set forth in the Trust's disclosure documents. Recommendations from management may be submitted to the Committee Chair. All recommendations shall include all information relating to such person that is required to be disclosed in solicitations of proxies for the election of Board members and as specified

in the relevant Trust's By-Laws, and must be accompanied by a written consent of the proposed candidate to stand for election if nominated for the Board and to serve if elected by shareholders.

4. Any shareholder nomination must be submitted in compliance with all of the pertinent provisions of Rule 14a-8 under the Securities Exchange Act of 1934 in order to be considered by the Committee. In evaluating a nominee recommended by a shareholder, the Committee, in addition to the criteria discussed above, may consider the objectives of the shareholder in submitting that nomination and whether such objectives are consistent with the interests of all shareholders. If the Board determines to include a shareholder's candidate among the slate of its designated nominees, the candidate's name will be placed on the Trust's proxy card. If the Board determines not to include such candidate among its designated nominees, and the shareholder has satisfied the requirements of Rule 14a-8, the shareholder's candidate will be treated as a nominee of the shareholder who originally nominated the candidate. In that case, the candidate will not be named on the proxy card distributed with the Trust's proxy statement.

5. As long as a current Independent Trustee continues, in the opinion of the Committee, to satisfy the criteria listed above, the Committee generally would favor the re-nomination of a current Trustee rather than a new candidate. Consequently, while the Committee will consider nominees recommended by shareholders to serve as trustees, the Committee may only act upon such recommendations if there is a vacancy on the Board, or the Committee determines that the selection of a new or additional Trustee is in the best interests of the relevant Trust. In the event that a vacancy arises or a change in Board membership is determined to be advisable, the Committee will, in addition to any shareholder recommendations, consider candidates identified by other means as discussed in this Annex A.

6. With respect to candidates for Independent Trustee, a biography of each candidate shall be acquired and shall be reviewed by counsel to the Independent Trustees and counsel to the Trust to determine the candidate's eligibility to serve as an Independent Trustee.

7. The Committee may from time to time establish specific requirements and/or additional factors to be considered for Independent Trustee candidates as it deems necessary or appropriate.

8. After its consideration of relevant factors, the Committee shall present its recommendation(s) to the full Board for its consideration.